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Online Table 1: Characteristics of studies exploring the association of the consumption of fish and dementia risk categorized by 
their year of publication  
First 
Author 
(publicatio
n year, 
and study 
place) 
Participants’ 
recruitment and 
characteristics 
Baseline 
Frequency of 
Fish 
consumption 
Follow up: 
Sample size, 
methods, 
duration 
Endpoint 
outcomes: 
Dementia 
diagnosis criteria 
and number of 
cases 
Data analysis, 
Adjustment for 
confounders 
Findings 
Albanese et 
al[1]:  
Latin 
America, 
China and 
India 
The data from 
10/66 population-
based studies of 
dementia and 
aging in 10 
LAMICs was 
used.  The study 
was for 7 
countries. 
Residents of aged 
≥65 years were 
listed by means of 
door-knocking. 
Participants 
recruited in Jan 
2003-Nov 2007 
from 11 sites 
across 7 
countries. It 
included urban 
and rural sites 
(Peru, Mexico, 
China and India) 
Standardised 
questions on 
fish and meat 
intakes per 
week were 
measured in 
face-to-face 
interview. 
Frequency of 
intake were 
"never", "some 
days", "most 
days", and " 
everyday". 
The sample size 
is 14,960 for all 
7 counties 
including; Cuba 
(2,934), 
Dominican Rep 
(1999), Peru 
(1927), 
Venezuela 
(1939), Mexico 
(1997), China 
(2162), and 
India (1998).  
Response rates 
ranged from 80-
94%. 
Dementia status 
was assessed by 
10/66 diagnostic 
algorithm. There 
was a total of 
1,340 prevalent 
dementia cases, 
ranging from 6.3% 
to 11.7% by 
country. Dementia 
cases were 316 
(10.8%) for Cuba, 
235 (11.7%) for 
Dominican 
Republic, and 165 
(8.5%), 140 
(7.1%), 
171(8.5%), 137 
(6.3%) and 181 
(9%) for Peru, 
Venezuela, 
Mexico, China and 
India respectively. 
Data for 
fish/meat intakes 
of "most days" 
and "every day" 
were combined 
as one category. 
Poisson 
regression was 
used to calculate 
unadjusted and 
adjusted 
prevalence ratios 
(PR) for fish and 
meat 
consumptions for 
each Country. 
The following 
were controlled; 
Model 1 (age, 
sex and 
educational 
level), Model 2 
(family history 
There was consistent inverse 
association of fish consumption 
and dementia prevalence in all 
Countries except India. 
Prevalence Ratio (PR) ranged 
from 0.40(0.26-0.60) in China to 
1.13 (0.84-1.50) in India for the 
crude model. The crude PR was 
0.67(0.52-0.88) for Cuba, 
0.74(0.60-0.91) for Dominican 
Rep; and 0.83(0.61-1.14), 
1.11(0.83-1.49), 0.64(0.49-0.85) 
for Peru, Venezuela and Mexico 
respectively. The inverse 
association was reduced in 
Model 1 after adjustment for 
age, sex and educational level. 
The PR was 0.86(0.68-1.08), 
0.77(0.62-0.94), 0.87(0.64-1.20), 
0.92(0.69-1.23), 0.83(0.64-1.08), 
0.45(0.31-0.67) and 1.18(0.88-
1.58) for Cuba, Dominican Rep, 
Peru, Venezuela, Mexico, China 
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or urban site 
(Cuba, 
Dominican 
Republic and 
Venezuela). 
Affluent centres 
were avoided in 
the study. The 
10/66 study 
protocol 
questionnaires 
were used to 
collect participant 
data on 
sociodemographic 
characteristics, 
health status, 
health behaviours, 
and risk factor 
exposures, 
physical and 
neurological 
examination. 
of dementia, 
self-reported 
chronic diseases 
(stroke, diabetes, 
and CHD), ICD-
10 depression, 
and smoking 
habits, living 
arrangements 
and number of 
assets). Others 
included daily 
intake of 
fruits/vegetables, 
meat intake, and 
alcohol. 
Likelihood tests 
were carried out 
to test for 
departures from 
linearity, and to 
test for the 
hypothesis of a 
linear association 
between dietary 
intake and 
dementia 
prevalence. The 
associations for 
dietary fish, and 
meat, with 
dementia for all 
countries were 
and India respectively. There 
was not much change in PR after 
further adjustment in model 2 for 
family history of dementia, 
chronic diseases, depression, 
smoking, living arrangement and 
number of assets. The PRs for 
model 2 were 0.83(0.66-1.04), 
0.78(0.64-0.95), 0.84(0.61-1.14), 
0.92(0.68-1.26), 0.85(0.65-1.11), 
0.50(0.36-0.71) and 1.18(0.88-
1.59) for Cuba, Dominican Rep, 
Peru, Venezuela, Mexico, China 
and India. Additional 
adjustments including dietary 
meat, alcohol consumption, 
diary fruits and vegetables did 
not alter much the results, with 
PR of 0.81(0.65-1.02), 
0.80(0.65-1.00), 0.76(0.56-1.05), 
0.87(0.56-1.34), 0.81(0.62-1.08), 
0.58(0.39-0.85) and 1.47(0.92-
2.35) for Cuba, Dominican Rep, 
Peru, Venezuela, Mexico, China 
and India respectively.  Findings 
of meat consumption and 
prevalent dementia were 
inconsistent across all Countries. 
The PRs were 1.28(1.04-1.58) in 
Cuba to 1.52(1.16-1.99) in Peru, 
which remained statistically 
significant after potential 
confounders were adjusted for. 
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summarised in a 
2- fixed effect 
model meta-
analysis forest 
plots. 
However, the crude PR for 
China suggested an inverse 
relationship between meat 
consumption and risk of 
dementia (0.67; 95% CI: 0.50, 
0.90), which became statistically 
non-significant after adjustment.  
Findings from the fixed effect 
meta-analysis showed a 
combined PR of 1.19 (1.07-1.31) 
for meat and dementia and 
0.81(0.72-0.91) for Fish and 
dementia. 
Kim et 
al[2]:  
Korea 
Fifty-seven 
elderly patients 
aged≥65 years 
(19 males and 38 
female) were 
recruited between 
December 2008 
and January 2009 
from the Kuri 
Area in Korea. 
Patients were 
defined as 
demented with a 
Mini-Mental 
Status 
Examination-
Korean Version 
(MMSE-K) score 
of ≤21.   
A 51-item semi 
quantitative 
Food frequency 
questionnaire 
was used to 
measure the 
average and 
frequency of 
various food 
consumption. 
Measures of 
portion sizes 
were aided by 
food models 
and full scale 
photographs 
and intake 
analysed by 
Can-pro 
3.0(Korean 
57 participants 
were used 
(n=33 as group 
with dementia 
and n=24 as 
control) 
Mini-Mental 
Status 
Examination 
(Korean version 
MMSE-K) was 
used to detect 
dementia.  
MMSE-K score 
was used to 
categorise 
participants into 
normal group 
(score>21, [n=24]) 
and demented 
group (score ≤21 
[n=33]). 
 
 
 
 
Continuous 
variables were 
expressed using 
the mean and the 
SEM to compare 
case and control 
by using an 
independent t 
test. The 
proportions of 
nominal 
variables were 
compared using 
the χ2 test. 
Partial 
correlation 
analysis with 
adjustment for 
age, sex, height 
and energy 
Using Pearson correlation 
analysis and adjusting for age, 
sex, height and energy intake; a 
significant positive correlation 
was found between MMSE-K 
score and ἀ-linolenic acid (ALA; 
18:3n-3) and total n-3 PUFA 
erythrocytes level showing 
0.459, p<0.001, and 0.299, 
p=0.028 respectively. A non- 
significant, but positive 
correlation was found for DHA 
(22:6n-3) and eicosapentaenoic 
acid (EPA: 20:5n-3) with 0.231, 
p=0.093 and 0.108, p=0.436) 
respectively. The risk of mild 
dementia for highest tertile (3) of 
ἀ-linolenic acid (ALA; 18:3n-3) 
was 0.09(0.01-0.94) and for 
middle (2) tertile  was 0.36 
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Nutrition 
Society, Seoul, 
Korea). 
Participants’ 
blood samples 
were collected; 
gas 
chromatography 
was used to 
analyse fatty 
acid methyl 
esters. 
Identification of 
fatty acids was 
done by 
comparing with 
known 
standards. 
Erythrocyte 
fatty acid 
composition 
and dietary 
intake were 
categorised into 
tertiles (1, 2 and 
3). 
intake was used 
to assess the 
relationship of 
erythrocyte fatty 
acid composition 
with dietary 
intake and 
MMSE-K score. 
Multivariate 
logistic 
regression was 
used to compute 
the Odds ratio 
and 95% CI for 
specific fatty 
acids of 
erythrocytes and 
dietary intake 
after adjusting 
for age, sex, 
height, and 
energy intake.   
(0.05-2.84) as compared to the 
lowest tertile (1). For n-3 PUFA, 
the risk for highest tertile (3) and 
middle tertile (2) were 
0.68(0.12-3.77) and 0.53(0.09-
3.18). In DHA (22:6n-3), the 
risks were 0.70(0.13-3.75) and 
0.46(0.07-3.08), for EPA 
(20:5N-3) the risk for the highest 
tertile (3) and middle tertile (2) 
were 1.61(0.22-11.94)) and 
3.53(0.52-24.02) and for DPA 
(22:5n-3) the risk for the highest 
(3) and middle tertile (2) was 
0.31(0.05-1.91) and 0.73(0.13-
4.32) respectively after adjusting 
for age, sex, height and energy 
intake.  
 
In addition, multivariate-
adjusted regression analysis and 
Pearson correlation analysis 
showed that any nutrient intake 
was not significantly related with 
the risk of mild dementia, and 
with MMSE-K score after 
adjusting for age, sex, height, 
and energy intake. These 
included protein, fat, fibre, 
calcium, phosphorus, iron, 
sodium, potassium, zinc, vitamin 
A, vitamin E, vitamin B1, 
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vitamin B2, vitamin B6, niacin, 
and folic acid. 
 
No significant relationship was 
found with erythrocyte saturated 
fatty acid, trans-fatty acids, n-6 
fatty acids, EPA, DPA and DHA 
and   the risk of dementia and 
MMSE-K score. 
 
Tully et 
al[3]: 
Ireland 
Patients attending 
a clinic at St 
James Hospital in 
the Mercer 
Institute for 
research and 
aging were 
invited to 
participate in a 
multi-factorial 
study on patient 
with AD. The 
participants were 
free living in the 
community and 
consisted of 119 
females and 29 
males aged 
between 49 to 92 
(mean age 76.5) 
(SD 6.6) with 
mean clinical 
dementia rating 
Plasma 
cholesteryl 
ester-fatty acid 
composition 
was used as an 
established 
biomarker of n-
3 PUFA and 
used to 
determine the n-
3 PUFA status 
in each patient. 
Specific fatty 
acid levels were 
presented as 
g/100g total 
fatty acids. The 
fatty acid 
compositions 
for both patients 
and control 
were randomly 
analysed. 
A total of 148 
subjects as 
cases (119 
females and 29 
males) and 45 
subjects as 
control subjects 
(36 females and 
9 males) were 
used. Non-
fasting serum 
samples from 
control subjects 
were taken. 
Those with 
history of 
stroke, 
hypertension, 
MMSE score 
<24 and current 
warfarin 
therapy were 
excluded.  The 
All cases met the 
criteria for 
NINCDS-ADRDA 
and ICD-10 
criteria. They were 
all diagnosed using 
detailed 
neuropsychologica
l testing and 
neuroimaging.  
Diagnosis included 
probable AD 
(108), possible AD 
(16) mixed AD 
(13) and vascular 
dementia (11). 
The analysis was 
conducted using 
ANOVA to 
describe 
differences 
between groups. 
Step-wise 
multiple 
regression 
analysis was 
used to ascertain 
the importance 
of age, sex and 
fatty acid 
composition on 
AD status. 
Parametric tests 
were done, after 
log 
transformation of 
fatty acids to 
produce 
Plasma cholesteryl ester levels of 
linoleic acid (18:2n-6) and total 
n-6 PUFA were lower (p<0.005) 
in the lowest quartile of MMSE 
score of the patients compared 
with controls. There were no 
significant lower levels in the 
other quartiles. Plasma levels of 
cholesteryl-EPA(20:5n-3) and 
DHA (22:6n-3) were lower 
(p<0.05 and p<0.001 
respectively) in all MMSE score 
quartiles of patients with AD 
compared to control. For total n-
3 PUFA (that includes ἀ-
linolenic acid, 18:3n-3), the three 
highest MMSE score quartiles 
were different from controls 
(p<0.001). Patients with AD had 
lower levels (p<0.001) of n-3 
PUFA compared to control.  The 
levels of DHA was not 
significantly different in those 
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(CDR) of 1(SD 
0.62). The mean 
MMSE score was 
19.5 (SD 4.8) 
(Range (2-27).  
Control 
participants aged 
between 53-81 
years (average 
age 70 years) (SD 
6) with no 
impairment in 
cognitive function 
were selected 
from an active 
elderly retirement 
group after 
undergoing 
dementia 
screening test 
with MMSE 
(MMSE 
score<24). They 
consisted of 36 
females and 9 
males and have 
mean MMSE 
score of 28.9 (SD 
1.1) (range 25-
30).  Every 
control 
participants were 
evaluated using 
average storage 
period of the 
serum samples 
was 2.54 years. 
Gaussian 
distribution. 
with clinical diagnosis of AD 
examined across age quartiles 
but lower than control 
consistently. For CDR, based on 
regression equation (r 0.429, 
p=0.0008), the MMSE score was 
predicted by cholesteryl ester-
DHA (β-0.517, P=0.0006), 
Cholesteryl ester-total saturated 
fatty acid levels (β 1.224, 
p=0.0044) and age (β 0.021, 
p=0.0052). Also, based on the 
regression equation (r 0.352, 
p=0.0001), MMSE score was 
predicted by cholesteryl ester-
DHA (β 4.048, P=0.0010 and 
cholesteryl ester-total saturated 
fatty acid levels (β-7.48, 
p=0.034). Age was not a 
significant predictor for the 
MMSE score (β -0.101, 
p=0.100). 
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their medical 
history, brief 
neurological 
assessment, 
height, weight 
and blood 
pressure. 
Conquer et 
al[4]: 
Canada 
A total of 96 
participants were 
selected for the 
study. Eighty-four 
(84) of them were 
recruited from a 
large Urban 
Centre, screened 
for an ongoing 
longitudinal study 
and all donated 
blood samples for 
investigation. 
Each person had 
thorough physical 
examination, 
computed 
tomography (CT) 
scan and detailed 
neuropsychologic
al assessment by 
a geriatrician. 
Other included 
haematology, 
renal, liver and 
metabolic 
Fatty acids 
composition 
which includes; 
20:5n-3, DHA, 
total n-3 fatty 
acids, and n-
3/n-6 ratio were 
assessed in 4 
different 
fractions of 
plasma lipids 
[total 
phospholipid, 
phosphatidylch
oline (PC), 
phosphatidyleth
anolamine (EP), 
and 
lysophosphatidy
lcholine 
(lysoPC)]. 
Total 
participants 
were 84. This 
was subdivided 
into 4 groups 
namely; Normal 
control group 
(19), AD group 
(19), other 
dementia (OD) 
(10) and CIND 
(36). 
AD group (19) 
were diagnosed 
based on NINCD-
ADRDA criteria 
for probable AD. 
Decisions of the 
criteria being met 
were jointly agreed 
by a board-
certified 
geriatrician and a 
board-certified 
neuropsychologist.  
All individuals 
were screened to 
ensure they did not 
have alternative 
causes of dementia 
like chronic 
alcohol/drug 
abuse, chronic 
infections, stroke, 
hypoxia, metabolic 
disorders, 
nutritional 
disorders, 
Comparison of 
demographic 
characteristics 
among groups 
and fatty acid 
composition 
were analysed by 
ANOVA, 
followed by least 
square means if 
P<0.05. Analysis 
of covariance 
(ANCOVA) was 
done with 
adjustment for 
age and 
education, where 
p<0.05. Least 
squared means 
analysis was 
only done where 
p<0.05 from the 
ANCOVA. 
The levels of 20;5n-3, DHA, 
total n-3 fatty acids and the n-
3/n-6 ratio for plasma 
phospholipid and PC were lower 
in the AD, OD and CIND groups 
than the control. Similarly, for 
plasma PE, the levels of 20:5n-3, 
DHA, and the total n-3 fatty acid 
except n-3/n-6 ratio, were 
significantly lower in the AD, 
OD and the CIND groups. For 
the LysoPC fraction, there was 
no statistically significant 
difference in the fatty acid 
composition (p>0.05) except for 
DHA that was significantly 
lower only in the CIND group 
(0.1%) compared to AD 
(0.49%), od (0.4%) and normal 
(0.48%). Plasma phospholipid 
24:0 was lower in the AD, OD, 
and the CIND compared to 
normal group. Total n-6 fatty 
acid levels were lower in the AD 
and CIND groups only. 
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function tests. 
Participants were 
classified into 4 
groups; normal 
control group, 
AD group, other 
dementia (OD) 
group and CIND 
(Cognitively 
Impaired Non-
Demented) group. 
Normal control 
group (19) 
participants were 
assessed by a 
battery of 
neuropsychologic
al examination to 
ensure normal 
cognitive 
functioning was 
intact. Brain 
damage, 
psychiatric 
illness, alcohol or 
drug abuse or 
brain related 
medical illness 
were assessed by 
a physician to 
ensure this was 
excluded. 
intracranial mass 
lesions, psychoses, 
brain trauma and 
other neurological 
disease. For the 
OD group (10) 
each person met 
the DSM-IV 
criteria, with cause 
not due to AD. 
Eight of them had 
VaD based on 
DSM-IV criteria 
and vascular 
lesions detected by 
a CT scan. One 
had alcohol related 
dementia and 
another due to 
head trauma. In the 
CIND group (36) 
diagnosis was 
reached if a 
participant did not 
meet the DSM-IV 
criteria but scored 
less than the value 
the age bracket 
from a 
neuropsychologica
l examination. 
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Barberger-
Gateau et 
al[5] : 
France 
Based on the data 
from PAQUID 
epidemiological 
study of cognitive 
and functional 
ageing, during the 
3rd wave of the 
study (1991-2), 
the investigators 
visited 1674 aged 
68 and over 
without dementia 
and living at 
home. 
[?General 
population, men 
and women] 
Each participant 
was visited to 
record their 
frequency of 
consumption of 
meat and fish or 
seafood at 
Daily, at least 
once weekly 
(but not every 
day), from time 
to time (but not 
every week), 
never. 
1,416 
participants 
(84.6%) were 
followed up at 
least one of the 
follow up visit 
at 2, 5 and 7 
years afterwards 
from the 
baseline.  
 
The lost follow-
up rate: 15.4% 
over the 7 years 
follow up. 
The participant 
who had lost >= 3 
points on the MSE 
since a previous 
visit or suspected 
of having dementia 
according to the 
DSM-III-R.  
The dementia 
diagnosis above 
was confirmed by 
a neurologist after 
visiting patient.  
170 new cases of 
dementia 
occurring over the 
7 years (135 AD) 
A Cox model 
with delayed 
entry to estimate 
the RR of 
dementia, taking 
into account age, 
sex and 
education (at 
least the French 
primary school 
diploma vs less 
education) 
Crude incidence of dementia per 
100 person years:  1.0 (95%CI 
0.00-2.97) in those who ate fish 
“Daily”, 2.05 (1.69-2.41) in “at 
least Once a week”, 2.90(1.94-
3.87) in Time to time, and 6.61 
(2.51-10.7) in "Never", trend 
p<0.0091. The data for AD was 
1.0 (0.00-2.97), 1.64 (1.31-1.96), 
2.24 (1.39-3.08) and 5.29 (1.62-
8.95) respectively, looking a 
significant trend.  
 
The RR of incident dementia in 
participants who ate fish or 
seafood at least once a week was 
0.66 (0.47-0.93) after adjustment 
for age and sex. The data for AD 
was 0.69 (0.47-1.01). 
After adjusted for age, sex and 
education, the RR for dementia 
was 0.73 (0.52-1.03), but no data 
for AD was reported.  
 
But in another paper by this 
author published in 2004, an age, 
sex, education adjusted AD risk 
of HR 0.77(0,52-1.14) for 
regular fish eaters was reported. 
Barberger-
Gateau et 
al[6]: 
France 
9294 non-
institutional 
participants aged 
≥65 years were 
Fish 
consumption 
level of the 
participants 
8085 
participants 
(89.1%) were 
followed up and 
The participants 
underwent three-
step-procedures 
(psychological 
A multivariate 
adjusted model 
was used to 
estimate the HR 
Age-adjusted HR for incidence 
of dementia for participants that 
consume fish for ≥4 times/week 
was 0.70(0.39-1.26), 2-3 
11 
 
 
 
recruited at 
baseline in the 
Three City 
prospective 
cohort study of 
vascular risk 
factors for 
dementia between 
1999 and 2000. 
 
were examined 
using a short 
FFQ that 
comprises of 
several dietary 
categories 
among which 
are fish with 
seafood, meat 
and poultry at 
the level of 
Daily, 4-6 times 
a week, 2-3 
times weekly, 
once a week, 
less than once a 
week, never. 
re-examined at 
least once over 
a 4years period 
from baseline.  
 
10.9% 
participants 
were lost to 
follow-up over 
4 years’ (mean 
3.48) period 
assessment, 
neurologist 
examination in 
only two out of 
three study area 
(Bordeaux 
Montpellier) while 
only those that 
showed positive 
signs of dementia 
in Dijon study area 
were further 
reassessed by 
neurologist due to 
the number of 
participants. Final 
examination was 
done by committee 
of neurologists 
using the DSM-IV 
criteria for 
dementia diagnosis 
and   NINCDS- 
ADRDA for AD.  
  
281 new cases of 
dementia occurred 
over a period of 4 
years with (183 
AD) 
of dementia and 
AD by   
adjusting for age, 
sex, education, 
city, income, 
marital status, 
BMI, diabetes, 
and ApoE 
times/week was 0.69(0.49-0.97) 
and for once/week was 
0.80(0.56-1.13). After further 
adjustment with sex, education, 
city, income and marital status 
(model1), the HR for ≥4 
times/week changed to 
0.81(0.45-1.46), 2-3times/week 
fish consumers had 0.68(0.48-
0.98) and once/week fish 
consumers had 0.81(0.57-1.17). 
 
When APOE status was 
introduced into the already 
adjusted model, HR for 
incidence of dementia for APOE 
carrier that consume fish ≥4 
times/week was 0.34(0.04-2.81), 
HR for fish consumers of 2-3 
times/week was 1.19(0.52-2.74), 
and once/week fish consumption 
was 1.50(0.65-3.44). For APOE 
non- carriers HR for ≥4 
times/week fish consumption 
was 0,80(0.41-1.58), 2-3 
times/week was 0.53(0.34-0.82), 
for once/week 0.66(0.42-1.01).  
 
When BMI and diabetes was 
added into the adjusted model, 
HR for APOE carrier for ≥4 
times/week fish consumption 
was 0.36 (0.04-2.91), 2-
12 
 
3times/week was 1.24 (0.53-
2.90) and once/week 1.66 (0.72-
3.83). For APOE non-carriers 
the HR was 0.78(0.39-1.58), 
0.54(0.35-0.85) and 0.64(0.41-
1.00) at fish consumption level 
of ≥4 times/week, 2-3times/week 
and once/week respectively. 
 
Age-adjusted HR for incidence 
of AD for participants that 
consume fish for ≥4 times/week 
was 0.60(0.29-1.24), 2-3 
times/week was 0.62(0.41-0.94), 
and for once/week was 
0.69(0.46-1.05). Additional 
adjustment with sex, education, 
city, income and marital status 
gave HR of 0.71(0.34-1.51) for 
≥4 times/week, 0.63(0.41-0.97) 
for 2-3 times/week and 
0.72(0.47-1.12) 
for once/week  
 
When APOE status was 
introduced into the already 
adjusted model, HR for 
incidence of AD for ≥4 
times/week fish consumption 
was 0.59(0.25-1.35), 2-3 
times/week was 0.60(0.38-0.94), 
and once/week was 0.74(0.47-
1.17).  
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When BMI and diabetes was 
added into the adjusted model, 
HR for ≥4 times/week fish 
consumption was 0.58(0.25-
1.34), 2-3times/week was 
0.59(0.37-0.94), and once/week 
was 0.74(0.46-1.17). 
 
A borderline significant 
reduction in the risk of dementia 
was found among frequent fish 
consumers of at least once a 
week after adjusting for age, sex, 
education, city, income, and 
marital status (model1) with HR 
(0.75(0.54-1.04). When the 
model was stratified with APOE 
status, a significant reduction in 
the risk of dementia was found 
among the APOE non carriers 
HR 0.60(0.41-0.89), while 
APOE carriers had a non-
significant reduction HR 
1.28(0.58-2.83).  
Further adjustment with BMI 
and diabetes did not affect the 
beneficial effect that frequent 
fish consumption has with 
dementia risk with HR 
0.60(0.40-0.90). Similar 
significant reduction was found 
among the frequent fish 
14 
 
consumers and AD risk in the 
fully adjusted model HR (0.65-
0.43-0.994)   
 
Consumption of fruit and 
vegetables lead to reduced risk 
of all cause dementia, giving a 
HR of 0.72 (0.53-0.97) fully 
adjusted. 
Devore et 
al[7]: 
Netherland
s 
7983 (78%) 
eligible 
inhabitants aged 
55 years or more 
were recruited at 
baseline based on 
agreement (1990) 
in the Rotterdam 
population based 
Study. Health and 
lifestyle 
information were 
collected at the 
commencement 
of the study 
(1990-1993). This 
involve an 
extensive home 
interview and 2 
clinical 
assessments. 
Participants 
comprises of both 
male and female   
A 2-step 
protocol was 
employed to 
collect dietary 
intake data. 
This include: a 
meal-based 
check list to 
prompt recall of 
food that were 
previously 
consumed at 
least 
twice/month A 
validated 170 
items SFFQ 
was later 
employed to 
collect the 
frequency of 
fish intake from 
each participant 
by a trained 
dietitian. 
7046(88%) of 
the chosen 
cohort that 
underwent 
cognitive 
screening were 
all confirmed 
free of 
dementia. They 
were followed 
up with a mean 
of 9.6 years. 
6444 
participants 
were left after 
exclusion of 
602 due to 
questionable 
cognitive status 
and bias in diet 
recall mainly 
because of 
living in 
nursing home. 
A 3-step protocol 
was used at 
baseline for 
dementia 
diagnosis: These 
comprises of 
MMSE and 
Geriatric mental 
state (GMS) 
schedule. Those 
that present with 
MMSE scores of 
<26 or GMS 
scores >0 
underwent the 
Camdex test, and 
suspected 
participants with 
dementia were 
further evaluated 
by a neurologist 
and 
neuropsychologist 
using 
Age-sex-
adjusted Cox 
hazard models 
and multivariate-
adjusted model 
were used to 
estimate the HR 
of dementia, 
controlling for 
education, total 
energy intake, 
alcohol intake, 
smoking, BMI, 
high total 
cholesterol, 
baseline 
hypertension, 
intake of vitamin 
E, supplement 
use, history of 
stroke, MI and 
type 2 diabetes. 
 
After adjusting for age and sex, 
the HR for higher fish 
consumption (29.6g/day) to 
dementia risk was 0.93 (95%CI 
0.74-1.17) and 0.99(0.77-1.29) 
for AD, when compared to never 
eaters over a longer period. 
Further adjustment with 
probable confounders showed 
HR of 0.95(0.76-1.19) for 
dementia and 0.99(0.76-1.29 for 
AD when compared to never 
eaters.  
 
Low fish consumption 
(8.2g/day) and dementia risk 
shows HR of 0.91(0.73-1.14) 
and 1.05(0.82-1.34) for AD 
when adjusted for age and sex. 
After further adjustment with 
potential confounders, the HR 
for dementia risk was 0.94(0.75-
1.17) and 1.07(0.83-1.37) for 
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This frequency 
was recorded in 
times per day, 
week, or month.  
Total fish intake 
was assessed 
using 3 
categories: 
(none, low and 
high); while the 
fish type was 
classified as 
“none”, “lean” 
and “fatty fish”. 
Total Omega-3 
PUFA 
(EPA+DHA, 
and ALA),was 
calculated for 
each 
participant, 
mainly 
attributable to 
mackerel and 
herring intake.. 
Further 
exclusion of 
1049 
participants 
were due to 
inconsistencies 
in dietary 
response, 
missing the last 
visit and not 
having a 
dietician 
available at the 
last visit. This 
reduced the 
final cohort to  
5,395 
participants that 
were 
undemented and 
had complete 
dietary 
information for 
analysis.  
 
 
 
neuroimaging data 
to identify brain 
abnormalities. 
Further monitoring 
of participants was 
done to establish 
any memory 
problem and 
dementia state 
using a 
computerized 
linkage of dataset 
and digitalized 
medical records. 
Lastly, the 
dementia diagnosis 
was confirmed 
using 3 experts’ 
committee 
following the 
DSM-III-R criteria 
for dementia, 
NINCDS-ADRDA 
for AD, and 
NINDS-AIREN 
for vascular 
dementia.   
465 new cases of 
dementia were 
developed over 9.6 
years’ follow-up 
period (with 365 
AD cases). 
The ratio of the 
total omega-3 
PUFAs to 
linoleic acid 
intake was 
grouped into 
quartiles, with 
the lowest 
quartile serving 
as the reference 
category.  
 
To examine the 
disparity in the 
relation that fish 
and omega-3 
PUFAs have 
with dementia 
using the follow 
up period, the 
follow up years 
was divided into 
two (longer (9-
14years) and 
shorter (0-
8years) follow 
up period to 
produce equal 
number of cases 
for analysis. 
AD, when compared to never 
eaters.  
 
When fish type (fatty fish) was 
considered and compared with 
never consumers of fish, similar 
HR 0.98(0.77-1.24) for risk of 
dementia was found, which was 
quite alike to the AD result (HR 
not reported).   
No relationship was also found 
with dementia risk when higher 
tertile of long chain omega-3 
PUFA was compared with lower 
tertile of omega-3 PUFA with 
(HR, 0.97; 0.77-1.21) in the 
multivariate adjusted model. 
This was quite similar to that of 
AD with HR of 1.05(0.81-1.36).  
The age-adjusted model for 
dementia risk showed HR of 
0.93(0.74-1.16) when the highest 
(3rd) tertile intake of omega-3 
PUFA was compared with 
lowest (1st) tertile intake level, 
and HR of 0.90(0.73-1.12) when 
the 2nd tertile omega-3 PUFA 
intake level was compared with 
the lowest tertile. 
No relationship of dementia risk 
was also found with the highest 
tertile intake of EPA, DHA and 
ALA when considered 
16 
 
independently with HR of 
0.97(0.77-1.21) and 0.99(0.79-
1.24) (HR of ALA not 
reported).in comparison with 
lowest tertile in the multivariate 
adjusted models. While HR of 
2nd tertile EPA and DHA intake 
level for risk of dementia when 
compared with their lowest 
tertile intake level was 
0.87(0.70-1.08) and 0.91(0.73-
1.13) respectively., ALA for 2nd 
tertile not HR reported 
Further analysis was done by 
comparing shorter follow up 
years (0-8) with longer years (9-
14).  The follow up period of 0-8 
years showed a reduced risk of 
Alzheimer’s disease with higher 
fish consumption   and long 
chain omega 3 PUFA intake 
with HR 0.78(0.53-1.16) and 
0.76(0.51-1.13) respectively, but 
no relationship was found over a 
period 9-14 years with HR 1.20 
(0.85-1.72) for higher fish 
consumption and 1.16(0.84-
1.60) for 3rd tertile long chain 
omega -3 PUFA. The low fish 
consumption level showed an 
increased risk of AD for follow 
up period of both 0-8 years and 
9-14 years with HR of 1.02 
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(0.71- 1.45) and 1.13 (0.80-1.61) 
when compared to never eaters. 
While for 2nd tertile long chain 
omega 3 PUFA intake a reduced 
risk with HR 0.87 (0.61-1.23) 
was found for 0-8 years follow 
up period and increased HR 1.07 
(0.78, 1.47) was found for 2nd 
tertile long chain omega 3 PUFA 
of 9-14 years follow up period. 
Similar trend was reported for 
risk of dementia but the HR 
result was not shown. 
 
 
 
 
Morris et 
al[8]: 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
8501 participants 
aged ≥65 years in 
the Chicago 
health and Aging 
Project, a 
population based 
cohort study of 
risk factors for 
incident AD were 
recruited at 
baseline between 
1993-1997 during 
the south-side 
Chicago III 
census 
programme with a 
Dietary intake 
was examined 
using a 154 
items FFQ that 
comprises of 4 
seafood and 
other food 
items. This 
includes tuna 
fish sandwich, 
fish sticks/fish 
cakes/fish 
sandwich, fresh 
fish as a main 
dish and 
815 participants 
who had full 
fish intake data 
for an average 
followed up 
period of 3.9 
years were used 
for the analysis. 
This was gotten 
from the 842 
people that 
accepted to 
participate from 
the 2nd 
randomization 
stage of 
AD status was 
established 
through series of 
neurological 
examination. This 
was performed by 
specialists’ team of 
neuropsychologica
l technician, 
neurologist, nurse 
practitioner, 
phlebotomist. MRI 
was employed for 
participants with 
dementia evidence, 
and to confirm 
Logistic 
regression model 
was used to 
produce OR as 
estimates of RR 
for incident AD, 
using the 
multivariable 
model. This 
controlled for 
race, sex, age, 
total energy 
intake, APOE4 
status,   
Age adjusted RR for incidence 
of AD for those that consume 
fish at least once/week was 0.5 
(95% CI 0.2-1.0), ≥twice/week 
was 0.6(0.2-1.4), 1-3 
times/month was (0.7, 0.3-1.6), 
when compared with non/rarely 
fish consumers. After further 
adjustment using the 
multivariable model for sex, 
race, education, presence of 
APOE4, and total energy intake, 
the RR was significant for those 
that consume fish at least 
once/week was 0.4(0.2-0.9), 
≥twice/week was 0.4(0.2-0.9) 
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61% female 
population. 
65% of the 
population was 
classified as 
black, 38% as 
white, with a 
mean educational 
level of 11.8 
years. 
shrimp/lobster/c
rab.  
 
The frequency 
was classified 
as: never, 1-
3times/months, 
once /week, 
≥twice/week 
during a mean 
period of 1.9 
years after their 
preliminary 
assessment or 
2.3 years before 
clinical 
examination).  
The summation 
of α-linolenic 
acid, EPA, 
DHA was used 
to estimate the 
total n-3 fatty 
acid intake. The 
summation of 
the responses 
given for the 
frequency of 
intake of the 3 
fish items was 
used for 
calculating the 
participants’ 
selection   
where 1249 
were chosen. 
 
 
 
 
 
 
 
 
 
 
 
stroke 
manifestation and 
if it was associated 
with incidence 
dementia. Finally, 
a confirmed 
neurologist 
without the 
knowledge of 
participant dietary 
intake reviewed 
the collected 
medical data using 
the  NINCDS- 
ADRDA for AD  
diagnosis      
 
131 new cases of 
AD occurred over 
a follow up period 
of 3.9 years  
Education, (race 
x APOE4 
interaction), 
Period of 
observation, 
indicator 
variable for fish 
consumption 
level 
For the total n-3 
fatty acid intake, 
the first quintile 
was used as the 
reference point 
 
 
 
but was non-significant for fish 
consumers of 1-3 times/month at 
0.6(0.3-1.3). 
 
Data was reanalysed using 
(n=641) participants after 
exclusion of those that declared 
an increase in weekly fish intake 
now compared to 10 years 
earlier and further controlling for 
stroke history, heart disease and 
hypertension. The RR for fish 
consumers of once/week was 
0.4(0.2-0.8) and 0.3(0.1-0.6) for 
≥twice/week. 
 
Age adjusted RR for incidence 
of AD for those that had total 
omega-3 PUFA at 5th quintile 
intake level was 0.3(0.1-0.7), 4th 
quintile intake was 0.6(0.2-1.5), 
3rd quintile intake was 0.5(0.2-
1.4) and 2nd quintile intake was 
1.1(0.4-2.9) in comparison to the 
lowest (1st quintile). After 
further adjustment with sex, 
race, education, presence of 
APOE4, and total energy intake, 
the RR of 5th quintile intake level 
for total omega-3 PUFA is 
0.4(0.1-0.9) which was 
significant, with the 2nd to 4th 
quintile being non-significant 
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weekly fish 
consumption.  
The 
consumption of 
n-3 fatty acids 
was divided 
into quintiles 
compared to the first quintile. 
The 4th quintile intake was 
0.7(0.3-1.6), 3rd quintile intake 
was 0.6(0.2-1.7) and 2nd quintile 
intake was 1.2(0.5-3.0) in 
comparison to the lowest (1st 
quintile). 
 
 
.  
 
 
Schaefer et 
al[9]: 
USA 
1921 participants 
both males and 
females aged 
between 55 and 
88 years who 
were alive and 
free of dementia 
were recruited at 
the 20th biennial 
examination cycle 
14-15 in the 
Framingham 
Heart Study that 
took place 
between the year 
1986/1988 till 
December 2002.  
 
 
 
 
Dietary fish and 
DHA intake 
were examined 
using a 126-
item semi-
quantitative 
food frequency 
questionnaire 
(FFQ). The 
participants 
were expected 
to have received 
and filled the 
questionaries’ 
before the 20th 
biennial 
examination. 
Total energy 
intake < 600 
calories and 
899 (74.4%) 
participants of 
the 1208 
(62.9%) with at 
least 1 year of 
follow up that 
took part in the 
baseline 
examination, 
provided 
plasma sample 
for PC fatty 
acid assessment 
and this 
constituted the 
study 
population. Of 
this study 
population, 488 
participants 
(54.3%) 
MMSE screening 
was performed on 
each participant at 
every biennial 
examination. 
Those that scored 
less than the 
education-based 
cut-offs or had lost 
>= 3 points on the 
MMSE, further 
had a neurological 
and a 
neuropsychologica
l examination.   
A comprehensive 
case review by 
board of at least 2 
neurologists and 
neuropsychologist 
were conducted for 
A Cox 
proportional 
hazards 
regression 
analyses was 
used to estimate 
the RR of 
incident 
dementia, 
controlling age, 
sex, ApoE, 
homocysteine 
concentration, 
education level, 
BMI, 
hypertension, 
diabetes 
mellitus, 
smoking status, 
alcohol intake, 
history of stroke, 
 A significant reduced risk of 
incident all-cause dementia was 
found among the participants in 
the plasma PC DHA highest 
quartile in comparison to those 
in the lowest quartile with RR of 
0.53(95%CI 0.29-0.98). Further 
adjustment with APOE allele, 
homocysteine concentration, and 
educational level, the RR was 
changed to 0.52(0.26-1.04), 
making this change non-
significant. However, when 
subjects with plasma PC DHA 
levels in the upper quartile were 
compared with all 3 lower 
quartiles combined, the RR was 
0.53 (95% CI 0.29-0.97) after 
adjustment. 
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>4200 calories 
excluded 
 
Fish intake was 
estimated in 
servings/ week. 
At baseline, this 
was 2.0 (2.0) 
for men and 2.1 
(1.8) for women 
 
Baseline plasma 
PC DHA levels 
was divided 
into four 
quartiles.    
provided dietary 
information.  
They were 
followed up 
over a period 16 
years with 
(mean of 
9.1years) 
 
 
each dementia 
diagnosis. The 
dementia and AD 
diagnosis were 
determined using 
the DSM-IV and 
NINCDS-ADRDA 
criteria 
respectively. All 
established 
dementia cases 
after the 20th 
biennial 
examination were 
included, while the 
previously 
established cases 
were excluded 
from the analysis. 
Subjects who had 
a stroke during 
follow up period 
was not excluded. 
  
99 new cases of 
dementia occurred 
during a mean 
follow up of 9.1-
year with (71 AD 
cases). 
   
daily calorie 
intake.  
A non-significant reduced risk of 
AD was found when participants 
in the highest plasma PC DHA 
quartile level was compared with 
the other 3 lower quartiles with a 
RR 0.60(0.32-1.12), when age 
and sex was adjusted, 0.59 (0.31-
1.14) when APOE allele was 
added into the adjusted model, 
and finally RR 0.61(0.31-1.18) 
when plasma homocysteine 
concentration and educational 
level was further introduced into 
the already adjusted model. 
 
No substantial change in the RR 
results for both the risk of 
dementia and AD was observed 
when BMI, hypertension, 
diabetes mellitus, smoking, 
alcohol intake, stroke history 
was later added to the already 
adjusted model with RR of 
0.54(0.29-0.98) compared to 
0.53 (0.29-0.97) for all-cause 
dementia and 0.62(0.32-1.22) 
compared to 0.61 (0.31-1.18) for 
AD. 
 
No significant relationship was 
found with all-cause dementia 
and AD risk, with plasma PC 
level of linoleic acid, α-linolenic 
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acid, eicosapentaenoic acid, 
palmitic acid, oleic acid, 
arachidonic acid, stearic acid in 
an age-sex adjusted model 
except with the RR 1.27(1.01-
1.61) of plasma PC level of 
linoleic acid in association with 
AD risk. The significant 
association changed when 
APOE, educational level and 
homocysteine was introduced 
into the adjusted model with RR 
1.24(0.97-1.59). 
 
A non-significant reduced risk of 
dementia and AD was found 
among participants at upper 
quartile dietary DHA intake 
level when compared to those at 
lower 3quartiles dietary intake 
level after adjusting for probable 
confounders with RR of 
0.56(0.23-1.40) for dementia and 
0.63(0.23-1.72) for AD. In the 
participants that consumed fish 
for ≥twice/week when compared 
with those that consumed fish 
for at most twice/week, a non-
significant reduction in the risk 
of dementia and AD was found 
with RR of 0.61(0.28-1.33) and 
0.50(0.20-1.27) respectively. 
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Lopez et 
al[10]:   
USA 
A total of 1692 
non- 
institutionalised 
individuals aged 
≥55 years partook 
in a clinic 
research visit in 
1988-91 based on 
the Rancho 
Bernardo study of 
heart and disease 
risk factors that 
enrolled 82% 
individuals 
between the year 
1972 and 1974, 
where diet and 
dementia status 
were examined 
using a validated 
self-administered 
food frequency 
questionnaire and 
neuropsychologic
al test battery. 
 
In 1991-1993, 
thorough clinical 
examination was 
further conducted 
on 326 
participants aged 
≥65 that were 
Dietary DHA 
and fish 
consumption 
data were 
obtained from 
the earlier visit 
in 1988-91, 
using a self-
administered 
semi-
quantitative 
Harvard Willett 
Diet 
Assessment 
Questionnaire 
and the food 
composition 
database. 
Three exposure 
variables; 
Plasma DHA, 
dietary DHA 
and 
consumption of 
dark-meat fish 
were used. 
Plasma DHA 
was categorised 
into tertiles 
(total weight 
%). Tertile one 
(1.28), tertile 
two (1.51) and 
402 community 
dwelling 
individuals 
participated in a 
research visit at 
a clinic in 1988-
91 and again in 
1991-93, 
but only 266 
eligible male 
and female 
participants 
aged ≥65 years 
had complete 
data for plasma 
DHA, out of 
which 242 had 
data for dietary 
DHA and fish 
consumption. 
Participants 
cognitive function 
that included 
MMSE and series 
of other 
assessments and 
clinical 
examination were 
evaluated by a 
psychometrics and 
neurologist 
respectively at the 
clinic visit. This 
was followed by a 
computerised 
tomography brain 
scan two weeks 
later, in 1991-93.  
NINCDS-ADRDA 
was later used for 
the diagnosis of 
all-cause dementia, 
which included 
AD, VaD, mixed 
dementia, and 
multi-infarct 
dementia.  
 
42 incident cases 
of possible or 
probable all-cause 
dementia occurred 
during the study 
Multivariate 
logistic 
regression was 
used to evaluate 
the relationship 
that each 
exposure 
variables has 
with odds all 
cause dementia 
and AD.  To 
adjust for 
skewed 
distribution, 
plasma and 
dietary DHA 
were log 
transformed and 
modelled as 
continuous, 
categorical 
(tertiles) and 
lowest tertile vs 
other tertile. 
Dark-meat fish 
was used as 
continuous 
variable of 
servings per 
week. 
Adjustments 
included age, 
sex, education, 
After adjusting for age, sex, 
education, ApoE and history of 
stroke, the odds of all-cause 
dementia for the highest tertile in 
plasma DHA was 0.35 (0.17-
0.92) and for AD it was 0.4 
(0.15-1.10). The odds for all-
cause dementia by the highest 
tertile in Dietary DHA was 0.27 
(0.09-0.79) and for AD it was 
0.28 (0.09-0.93). Using 
continuous variables, higher 
plasma DHA yielded odds of 
0.72 (0.49-1.05) for all-cause 
dementia and 0.76 (0.50-1.14) 
for AD. For higher dietary DHA, 
the OR was 0.53(0.34-0.81) for 
all-cause dementia and 
0.52(0.32-0.84) for AD.  The 
odds for the lower tertile 
compared to the others in the 
Plasma DHA was 2.35 (1.12-
4.92) for all-cause dementia and 
2.33(1.04-5.21) for AD. 
Similarly, the Odds for lower 
tertile in dietary DHA was 
4.31(1.87-9.92) and 3.43(1.42-
8.26) for all-cause dementia and 
AD respectively. In the analysis 
of the highest tertile, further 
adjustments for Systolic, 
smoking, alcohol, exercise, 
diabetes and BMI did not alter 
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classified as 
having a higher 
risk of dementia 
out of 1349 due to 
failure of ≥3 
screening 
assessments. 
 
tertile three 
(1.84). 
Similarly, for 
dietary DHA 
(grams/day), 
tertile one 
(0.12), two 
(0.13) and three 
(0.19). 
Responses on 
fish intake 
included; rarely 
or never, 1-3 
times/month, 1 
time/week, 2-4 
times per week, 
5-6 times per 
week, daily and 
2 times/day. 
period of which 30 
cases were AD. 
The remaining 224 
people had no 
dementia. 
ApoE4 status, 
stroke, systolic 
B.P, smoking, 
alcohol intake, 
exercise, 
diabetes and 
BMI. 
the associations. The exclusion 
of the ApoE4 Allele carriers did 
not substantially change the odds 
ratio of any of the result. 
For fish consumption, of at least 
one serving per week, the odds 
for all-cause dementia was 0.51 
(0.20-1.32) and for AD it was 
0.55 (0.20-1.48). 
Huang et 
al[11]: 
 USA 
The participants 
for the study were 
drawn from a 
sample of 5,201 
people (aged ≥65 
years) that were 
selected, for the 
Cardiovascular 
Health Cognitive 
Study (CHCS), in 
1989/90 from a 
randomised 
Medicare 
eligibility list of 4 
Various eating 
styles and 
habits, 
including fish 
consumption of 
each participant 
was assessed 
using a 
modified 
National Cancer 
Institute (NCI) 
99-item FFQ 
(with 46 extra 
questions). Fish 
A sample of 
2233 
participants 
with mean 
followed up 
period of 5.4 
years was used 
for the analysis.  
Diagnosis 
involved screening 
based on MMSE 
and subsequently 
3MSE, TICS for 
those absent at 
clinic and 
IQCODE 
administered to 
informants or 
physician in the 
case of death. All 
participants 
classified as high 
Cox hazard 
regression 
models were 
used to estimate 
the HR of 
dementia, AD, 
and VaD. Model 
1 included; 
baseline age, 
minority status, 
gender, APOE 
e4, energy 
intake, baseline 
BMI and region. 
There was no significant 
difference in risk of dementia or 
AD with greater servings per 
week of fried fish either before 
or after controlling for fatty fish, 
age at baseline, minority status, 
gender, presence of APOE e4, 
energy, BMI, region, education, 
or income. 
 
The univariate analysis shows a 
non-significant lower incident of 
dementia (HR 0.75 (95% CI 
0.55-1.03)) and AD (HR: 0.69 
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communities in 
the US. Another 
687 (African 
Americans) were 
recruited between 
1992 and 1993. A 
total of 3,602 
with completed 
MRI scan and 
Modified Mini-
Mental State 
Examination 
(3MSE) between 
1992 and 1994 
were assessed in 
1998.Out of 
these, 2,233 
people were 
followed- up from 
time of MRI to 
onset of AD, 
dementia or 
death, ranging 
between 0.1-8.4 
years (mean 5.4 
years). Excluded 
participants were; 
577 with MCI, 
227 prevalent 
dementia and 565 
lacking data on 
energy intake/fish 
intake/responses 
consumption 
was assessed in 
four categories 
of number of 
servings per 
week which 
included; <0.25, 
0.25-2, 2-4 and 
≥4 for fatty fish 
(other fish and 
tuna). For lean 
fried fish, it 
included; <0.25, 
0.25-2 and ≥2 
servings per 
week. 
risk (80-point 
cutoff on the 
3MSE, a decline of 
at least 5 points on 
the 3MSE from 
previous 
examinations, a 
TICS score of <28, 
an IQCoDE score 
of >3.6, a stroke, a 
medical record 
review with a 
diagnosis of 
dementia, or 
residence in a 
nursing home), at 
the Pittsburgh site 
and all minorities 
completed a 
neurological test 
battery and were 
further assessed by 
neurologist if tests 
of memory or 
>one cognitive 
domain were failed 
(If refused / unable 
to attend clinic, or 
was deceased, 
dementia was 
assessed using the 
prospectively 
Model 2 also 
included 
education and 
income.  
Analysis was 
done separately 
for fatty fish 
(other fish or 
tuna) at 4 levels 
of intake and 
fried fish at 3 
levels of intake 
and total fish at 4 
levels of intake. 
Analysis was 
also done 
according to 
APOE e4 status 
(i.e. Because 
the interaction 
between fish and 
APOE ε4 had 
p<0.10, authors 
subsequently 
stratified by 
presence of 
APOE ε4). 
(0.45-1.06)) in participants who 
ate tuna or other non-fried fish 
- once/month to twice a week in 
comparison to very low or non-
consumption.  Consumption of 
tuna or other non-fried fish 
≥4times /week, was significantly 
associated with protection 
against dementia (HR: 
0.63(0.44-0.90)) and AD (HR: 
0.56(0.34-0.91)). 
These associations were not 
significantly affected after 
adjusting for age at baseline, sex, 
minority status, presence of 
APOEe4, energy, BMI, region, 
and fried fish intake (model 1), 
for consumption of tuna or 
other non-fried fish the HR for 
dementia was 0.65 (0.43-0.98) 
for consumption ≥4times /week, 
0.72(0.51-1.02) for 2-4 servings 
/week and 0.76(0.55-1.06) for 
0.25-2 servings /week when 
compared to <0.25 servings / 
week. For AD the HR was 
0.54(0.31-0.95) for consumption 
of tuna or other non-fried fish 
≥4times /week, 0.59(0.36-0.95) 
for 2-4 servings /week and 
0.72(0.46-1.12) for 0.25-2 
servings /week when compared 
to <0.25 servings / week. After 
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from more than 
12 food items 
from the FFQ or 
extreme energy 
intake values. The 
variables 
collected   at 
baseline, apart 
from dietary 
intakes, included 
education, age, 
gender, BMI and 
income. APOE 
genotype was 
assessed through 
DNA analysis 
from 91.5% of the 
participants. 
collected data from 
the annual 
clinic examination, 
supplemented with 
data from medical 
records, 
physician 
questionnaires, and 
informant/proxy 
interviews 
(including 
the Dementia 
Questionnaire). 
Team of 
psychiatrists and 
neurologist finally 
certify dementia 
cases if he or she 
had had a 
progressive or 
static 
cognitive deficit 
severe enough to 
affect ADLs, a 
previously normal 
level of intellectual 
functioning, 
impairment in two 
or more 
cognitive domains 
that did not 
necessarily include 
memory, and if 
further adjustment with 
education and income (model 2) 
HR’s were attenuated for 
consumption of tuna or other 
non-fried fish. HR for dementia 
was 0.79(0.53-1.20) for ≥4times 
/week, 0.83(0.59-1.18) for 2-4 
servings /week and 0.85(0.61-
1.19) for 0.25-2 servings /week.  
For AD, HR was 0.69(0.91-1.22) 
for ≥4times /week, 0.72(0.44-
1.17) for 2-4 servings /week and 
0.85(0.54-1.33) for 0.25-2 
servings /week when compared 
to <0.25 servings / week. 
 A non-significant reduced risk 
of dementia and AD with total 
fish consumption was attained 
with fully adjusted HR of 
0.87(0.62-1.23) for >1 
servings/month to 2 
servings/week of total fish for 
dementia and 0.78(0.48-1.28) for 
AD.  
A non-significant increased risk 
of dementia with HR 1.11(0.76-
1.47) was found for intake of ≥2 
servings/wk of fried fish in 
(model 1) and 0.97(0.69-1.35) in 
model 2 when compared with < 
0.25 servings/week, while HR 
1.18(0.92-1.52) was found for 
consumption of 0.25-2 
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they fulfilled the 
DSM-IV criteria, 
AD cases using the 
NINCDS-ADRDA 
and VaD cases by 
means of ADDTC.  
Of the 2233 
assessed 
participants, 378 
had dementia, 190 
AD, 50 had pure 
VaD. 
 
servings/week of fried fish in 
model 1 and HR 1.12(0.87-1.44) 
in model 2. For AD, a non-
significant increased risk of HR 
1.06(0.66-1.69) was found for 
≥2 servings/week of fried fish in 
(model 1) and 0.95(0.60-1.52) in 
model 2, while HR 1.07(0.74-
1.54) was found for 0.25-2 
servings/week of fried fish in 
model 1 and HR 0.97(0.67-1.40) 
in model 2, when compared with 
<0.25 servings. HR of 2.6(1.39-
4.96) with increased risk of 
vascular dementia (VaD) was 
revealed after intake of 0.25-2 
servings of fried fish/week but 
the HR of 1.68(0.74-3.84) at 
fried fish intake level of 2-4 
servings/week was not 
significantly associated with 
VaD. Similar findings were 
found after adjusting for 
confounding variables. The HR 
result for VaD risk in relation to 
fatty fish intake was similar to 
that of risk of dementia but the 
findings were not reported. 
Findings from the analysis of 
dementia outcome and tuna or 
other fish stratified by APOE e4 
status showed a small or no 
relationship among APOEe4 
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positive participants that 
consumed 2-4 servings/week of 
fatty fish with HR 0.91(0.48-
1.71), while the APOEe4 
negative participants showed 
significantly lower HR 
0.60(0.40-0.89) after consuming 
2-4 servings/week of fatty fish. 
The HR was maintained for 
APOEe4 negative participants 
after controlling for confounders 
in model 1 but the association 
was attenuated in model 2. 
Adjusting for age, minority 
status, sex, APOE e4, energy, 
BMI, region, and fried fish in 
model 1 showed HR of 0.91 
(0.44-1.88) among APOE e4 
positive participants with ≥4 
servings per week compared to < 
0.25, and further adjustment 
using education and income 
(model 2) showed HR 1.03 
(0.49-2.16). The HRs for 2-4 
servings/week were 0.99 (0.52-
1.89) and 1.06 (0.55-2.05) for 
model 1 and model 2; and for 
0.25-2 servings/week the HR 
was 1.07 (0.58-1.98) and 1.23 
(0.66-2.30) for model 1 and 2 
respectively. For APOEe4 
negative participants that 
consumed ≥4 serving/ week of 
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tuna or other fish, the HR for 
model 1 was 0.54(0.31-0.95), 
HR for 2-4 servings of fish was 
0.59(0.36-0.95) and for 0.25-2 
servings of fish the HR was 
0.72(0.46-1.12), compared to 
<0.25 servings/week. Further 
adjustment (model 2) showed 
HR 0.69(0.91-1.22) for ≥4 
servings per week, HR 
0.72(0.44-1.17) for 2-4 
servings/week, and 0.85(0.54-
1.33) for 0.25-2 servings/week 
of tuna or other fish, compared 
to <0.25 servings/week.  
 
Summary: 
Fatty fish appeared to be 
associated with a greater 
reduction in dementia and AD 
than leaner fish, supporting the 
hypothesis that DHA is the 
primary protective nutrient in 
fish.  It presents findings 
stratified by APOE e4, 
suggesting that the presence of 
the e4 allele may modify the 
relationship of fatty fish to 
dementia and AD. 
Abbreviations: Mini-Mental State Examination-MMSE; Geriatric Mental State schedule-GMS; International Classification of Diseases, 10th revision-(ICD-10) criteria; Diagnostic and Statistical Manual 
of Mental Disorders-III-Revised-DSM-III-R; National Institute of Neurological and Communicative Diseases and Stroke Alzheimer’s Disease and Related Disorders Association-NINCDS-ADRDA; 
Food-frequency questionnaire-FFQ; Apolipoprotein E -APOE; Body Mass Index-BMI; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition DSM-IV; Semi-quantitative food-frequency 
questionnaire -SFFQ; Cambridge Mental Disorders of the Elderly Examination-CAMDEX, Hazard Ratio-HR; Odd Ratio-OR; Prevalence ratio-PR, Relative Risk-RR. Alzheimer’s disease-AD; WAIS-R–
Weschler Adult Intelligence Scale-Revised, Alzheimer’s Disease Diagnostic and treatment Center criteria -ADDTC 
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Online Table 2: The Pooled Analysis Results for Fish Consumption and AD Risk 
 Nos of 
Studies 
Nos of 
Studied 
populations 
Participants AD cases RR (95% CI) 
Country of study      
High income[6-12] 7 7 18,674 AD (1105) 0.73(0.65- 0.82) 
 
Design of study      
Cohort studies[6-
12] 
7 7 18,674 AD (1105) 0.73(0.65- 0.82) 
 
Cohort-studies 
(follow up ≤ 5 
years) [6, 8, 10] 
 
3 3 9,142 AD (344) 0.49(0.30-0.80) 
 
Cohort-studies 
(follow up year >5 
years)[7, 9, 11, 12] 
4 4 9,532 AD (761) 0.75 (0.66-0.84) 
 
Abbreviations: CI: Confidence Interval; RR: Relative Risk 
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Online Table 3: Dose-Response Data for Low, Middle and High Level of Fish Consumption 
- AD cases 
Level of Fish 
Consumed 
Nos of Studies Participants Alzheimer’s 
Dementia cases 
RR (95% CI) 
Low levels[6-9, 
11, 12] 
6 18,432 AD (1,075) 0.88 (0.74-1.04) 
 
Middle levels[6-
8, 10, 11] 
5 16,770 AD (899) 0.79 (0.65-0.96) 
 
High levels[6, 8, 
11] 
3 11,133 AD (504) 
 
0.67 (0.58-0.78) 
Abbreviations: CI: Confidence Interval; RR: Relative Risk 
 
 
Online Table 4: Data analysis for different Level of Fish Consumption - AD cases 
Data analysis for fish 
consumption level 
Nos of 
Studies 
Nos of 
Studied 
populations 
Participants AD cases RR (95% CI) 
Continuous[6-12]  7 7 18,674 1105 0.73(0.65- 0.82) 
Only 2 levels[9, 12] 2 2 1904 206 0.72 (0.50-1.03) 
Only 3 levels[7, 10] 2 2 5,637 395 0.95 (0.74-1.23) 
4 levels[6, 8, 11] 3 3 11133 504 0.67 (0.58-0.78) 
Abbreviations: CI: Confidence Interval; RR: Relative Risk. 
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Online Fig.1: Funnel plot for the publication bias 
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Online Figure 2:  Forest plot showing the association of the combination of all the fish 
consumption level and dementia risk 
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Appendix1 
Cross-sectional study 
The study by Albanese et al [1] investigated dietary fish and meat intake and dementia using the 
data from 10/66 population-based studies of dementia and aging in 10 Low and Middle Income 
Countries. The study suggested a dose-dependent inverse association between fish consumption 
and prevalence of dementia that was consistent in all sites except India. They however found a less 
consistent, dose-dependent and direct association for meat and dementia prevalence. The study 
was for 7 Countries. Residents aged ≥65 years were listed through door to door knocking and 
participants recruited in Jan 2003 to Nov 2007 from 11 sites across 7 Countries. It included Urban 
and rural sites (Peru, Mexico, China and India) or Urban sites alone (Cuba, Dominican Republic 
and Venezuela). The well-off areas were avoided. The 10/66 study protocol questionnaires were 
used to collect participants’ data on socio-demographic, health status, heath behaviours, and risk 
factor exposures as well as physical and neurological examination. The total sample size for the 
study was 14,960 for all Countries including; Cuba (2,934), Dominican Rep (1999), Peru (1927), 
Venezuela (1939), Mexico (1997), China (2162), and India (1998). Response rates ranged from 
80-94%.  Face to face interviews using standardised questions on fish and meat intakes per Week 
were used to gather data for frequency of intake as “never”, “some days”, “most days” and “every 
day”. Dementia status was assessed by the 10/66 diagnostic algorithm. For the data analysis, 
Poisson regression was used to calculate unadjusted and adjusted prevalence ratios (PR) for fish 
and meat consumptions for each Country. Likelihood tests were carried out to test for departures 
from linearity, and to test for the hypothesis of a linear association between dietary intake and 
dementia prevalence. The fish/meat intakes of “most days” and “everyday” were collapsed into 
one category resulting in categorical variables with three levels of intake. Finally, the associations 
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for dietary fish, and meat, with dementia for all counties were summarised in a 2- fixed effect 
model meta-analysis forest plots.  
The results of the crude models from the Poisson regression analysis showed consistent association 
of fish consumption and dementia prevalence in all Countries except India. It ranged from 
0.40(0.26-0.60) in China to 1.13 90.84-1.50) in India. The crude Prevalence Ratio (P.R) was 
0.67(0.52-0.88) for Cuba, 0.74(0.60-0.91) for Dominican Rep; and 0.83(0.61-1.14), 1.11(0.83-
1.49), 0.64(0.49-0.85) for Peru, Venezuela and Mexico respectively. After adjusting for age, sex 
and education in the first Model, the inverse association was reduced. The PR was 0.86(0.68-1.08), 
0.77(0.62-0.94), 0.87(0.64-1.20), 0.92(0.69-1.23), 0.83(0.64-1.08), 0.45(0.31-0.67) and 1.18(0.88-
1.58) for Cuba, Dominican Rep, Peru, Venezuela, Mexico, China and India respectively. There 
was no substantial change in PR after further adjustment in model 2 for family history of dementia, 
chronic diseases, depression, smoking, living arrangement and number of assets. The PRs for 
model 2 were 0.83(0.66-1.04), 0.78(0.64-0.95), 0.84(0.61-1.14), 0.92(0.68-1.26), 0.85(0.65-1.11), 
0.50(0.36-0.71) and 1.18(0.88-1.59) for Cuba, Dominican Rep, Peru, Venezuela, Mexico, China 
and India.  Additional adjustments including dietary meat, alcohol consumption, diary fruits and 
vegetables did not alter much the results.  Findings of meat consumption and prevalent dementia 
were inconsistent across all Countries. The PRs were 1.28(1.04-1.58) in Cuba and 1.52(1.16-1.99) 
in Peru, which remained statistically significant after potential confounders were adjusted for. 
However, the crude PR for China suggested an inverse relationship between meat consumption 
and risk of dementia (0.67; 95% CI: 0.50, 0.90), which became statistically non-significant after 
adjustment. The findings from fixed effect meta-analysis showed a combined PR of 1.19 (1.07-
1.31) for meat and dementia and 0.81(0.72-0.91) for Fish and dementia, both of which were 
statistically significant. The study demonstrated high quality based on assessment for cross-
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sectional design. However, exclusion of more affluent areas within countries for the study affects 
the generalisation of findings or comparison with those from the West or limit it to people with 
similar dietary and health features. Random errors with regards to reporting dietary exposures may 
have led to an underestimate of the true values. Selection bias could also not be excluded which 
might explain why those without dementia and reporting higher fish intake were more likely to 
participate in the study.  
 
Case-control studies 
The study by Kim et al [2]  evaluated the consistency of Country-specific hypothesis that n-3 
Polyunsaturated Fatty Acids (PUFA) of erythrocyte such as; α-linolenic acid (ALA), 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is associated with mild dementia 
using a Korean elderly population. They found that ALA from plant sources of n-3 PUFA 
decreased the risk of mild dementia but not the EPA and DHA from fish. The study involved 57 
elderly patients (38 females) aged ≥ 65 years, who were recruited between December 2008 and 
January 2009 from the Kuri area in Korea.  The average and frequency of various foods 
consumption were measured using a 51- item food frequency questionnaire. Measures of portion 
sizes were aided by full scale photographs, intake was analysed by a Can-pro 3.0 (Korean Nutrition 
Society, Seoul, Korea). The blood samples from participants were collected, gas chromatography 
was used to analyse fatty acid methyl esters. Identification of fatty acids was done by comparing 
with known standards. Erythrocyte fatty acid composition and dietary intake were categorised into 
tertiles (1, 2 and 3). Dementia diagnosis was done using Mini-Mental Status Examination (Korean 
version MMSE-K). The MMSE-K score was used to categorise patients into normal group 
(score>21) and dementia group (score ≤21) containing 24 and 33 participants respectively. 
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Continuous variables were expressed using the mean and the SEM to compare case and control by 
using an independent t test. The proportions of nominal variables were compared using the χ2 test. 
A partial correlation analysis with adjustment for age, sex, height and energy intake showed a 
significant positive correlation of MMSE-K score and fatty acids in erythrocytes for ALA 
(r=0.459, p<0.001) and total n-3 PUFA (r=0.299, p=0.028).  The results were, however, non-
significant for DHA (r= 0.231, p=0.093) and EPA (r=0.108, p=0.436).  A multivariate logistic 
regression, after adjusting for age, sex, height and energy intake showed a significant reduction in 
the risk for mild dementia (OR: 0.09, 95%CI: 0.01-0.94) for the highest tertile and non-significant 
association for the middle tertile (OR: 0.36, 95%CI: 0.05-2.84) when compared with lowest tertile 
of α-linolenic acid (ALA).  A non-significant risk reduction was observed for n-3 PUFA for the 
highest (OR: 0.68, 95%CI: 0.12-3.77) and middle tertile (OR: 0.53, 95%CI: 0.09-3.18). The 
finding was similar in the DHA for the highest (OR: 0.70, 95%CI: 0.13-3.75) and middle (OR: 
0.46, 95%CI: 0.07-3.08) tertile. However, in the case of EPA there was non-significant increase 
in the risk of mild dementia for the highest (OR: 1.61, 95%CI: 0.22-11.94) and middle (OR: 3.53, 
95%CI: 0.52-24.020) tertile. The study adjusted for very few covariates, with education not 
controlled in the analysis even though it is known to influence dementia risk. Participants were 
recruited from an area called Kuri in Korea. A description of this site or information of the 
population from which the sample was drawn was not provided. Neuropsychological evaluation 
was not detailed enough neither was disease history of the control group assessed. Information on 
the type of fish consumed and methods of cooking were not included, all of which may have been 
relevant factors. Adjustment for confounding factors did not eliminate the possibility of residual 
confounding also having an effect on the findings. It was therefore difficult to rule out cognitive 
impairment or diseases that may affect cognitive function in the control subjects used for the study. 
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      In 2003, Tully and colleagues [3] published a paper in the British Journal of Nutrition 
suggesting that low serum levels of cholesteryl ester-docosahexaenoic acid (DHA) levels was 
associated with Alzheimer’s disease, with total saturated fatty acid levels and the cholesteryl ester-
DHA as important determinants of MMSE score and Clinical dementia rating (CDR).  For the 
study, they recruited patients that attended clinic from the Mercer Institute for Research and aging 
at St James Hospital, as part of a multi-factorial study on patients with Alzheimer’s disease.  The 
participants were all free living in the community and consisted of 119 females and 29 males of 
age range 49-92 years (Mean 76.5, SD 6.6) and mean clinical dementia rating (CDR) of 1(SD 
0.62).  The mean MMSE score was 19.5 (SD 4.8) with range 2-27. The control group was recruited 
from an active elderly retirement people who were free of cognitive impairment with mean MMSE 
score of 28.9 (SD 1.1) with range 25-30. The total people for the control was 45 (36 females and 
9 males) of age 58-81 years (mean=70, SD 6.0). All participants had their medical history, brief 
neurological assessment, height, weight and blood pressure recorded. Those with history of stroke, 
hypertension, MMSE score <24, and on current warfarin therapy were excluded. Average storage 
period of serum samples was 2.54 years. Plasma cholesteryl ester-fatty acid composition was used 
as an established biomarker of n-3 PUFA and used to determine the n-3 PUFA status in each 
patient. Specific fatty acid levels were presented in g/100g total fatty acids. The fatty acid 
compositions for both patients and control were randomly analysed.  All cases met criteria for 
NINCDS-ADRDA and ICD-10 criteria and involved neuropsychological testing and 
neuroimaging. The analysis using ANOVA showed lower plasma levels of cholesteryl ester of 
linoleic acid and total n-6 PUFA (p<0.005) for the lowest quartile of MMSE score of patients 
compared with control. No significant lower levels were seen for other quartiles. Similarly, lower 
levels of plasma cholesteryl ester-EPA (p<0.05) and DHA (p<0.001) were observed in all MMSE 
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score quartiles for those with AD patients compared to control. For the n-3 PUFA, the three highest 
MMSE score quartiles were different from controls (p<0.001), and patients with AD had lower 
levels of n-3 PUFA. The level of DHA was not significantly different in those with AD examined 
across age quartiles even though they were lower than the control. Findings from multiple 
regression showed that for CDR, based on the regression equation (r 0.429, p=0.0008), MMSE 
score was predicted by both cholesteryl ester-total saturated fatty acid levels (β 1.224, p=0.0044) 
and age (β 0.021, p=0.0052).  Similarly, based on the regression equation (r 0.352, p=0.0001), 
MMSE score was predicted by cholesteryl ester-DHA (β 4.048, P=0.001) and cholesteryl ester-
saturated fatty acid levels (β -7.48, p=0.034). However, age was not a significant determinant (β-
0.101, p=0.100). The data analysis did not consider additional covariates apart from age. 
Therefore, it is likely that other important determinants like education and dietary habits could 
have been missed. The control subjects were reported to be younger than the cases. It is thus 
difficult to rule out the fact that it might have affected results since increased age is associated with 
cognitive impairment or dementia. 
      The study by Conquer et al [4] investigated the plasma fatty acid composition of various 
phospholipid fractions including; total phospholipids (PL), phosphatidylcholine (PC), 
Phosphatidylethanolamine (PE), and lysophosphatidylcholine (lysoPC) of Alzheimer’s disease 
(AD) patients and compared with those of elderly normal control subjects, other types of dementia 
(OD) and cognitive impairment (CIND). Their findings suggested that lower levels of n-3 fatty 
acids in the plasma of AD, OD and CIND individuals may be a risk factor for cognitive impairment 
and/ or dementia. A total of 96 participants were selected for the study. Eighty-four of them (84), 
who were recruited from a large urban centre and screened for an ongoing longitudinal study, all 
donated blood samples for investigation.  Each person had thorough physical examination, 
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computed tomography (CT) scan and detailed neuropsychological assessment by a geriatrician. 
Others included haematology, renal, liver and metabolic function tests. The participants were 
classified into 4 groups namely; normal control group (19), AD group (19), OD (10) and CIND 
group (36). The AD group were diagnosed based on NINCD-ADRDA criteria for probable AD 
with decisions agreed jointly by a board- certified geriatrician and neuropsychologist. All 
individuals were screened to ensure they did not have alternative causes for dementia like chronic 
alcohol/drug abuse, chronic infections, stroke, hypoxia, metabolic disorders, nutritional disorders, 
intracranial mass lesions, psychoses, brain trauma and other neurological disease.  The OD group, 
each person met criteria for DSM-IV, with the cause not due to AD. Eight of them had VaD based 
on DSM-IV criteria and vascular lesions detected by a CT scan. One had alcohol related dementia 
and another due to head trauma. In the CIND group (36) diagnosis was reached if a participant did 
not meet the DSM-IV criteria but scored less than the value for the age bracket from a 
neuropsychological examination. Fatty acid compositions were assessed in 4 different plasma 
lipids. Comparison of demographic characteristics among groups and fatty acid composition were 
analysed by ANOVA, followed by least square means if P<0.05. Analysis of covariance 
(ANCOVA) was done with adjustment for age and education, where p<0.05. Least squared means 
analysis was only done where p<0.05 from the ANCOVA. The analysis using ANOVA showed 
that the levels of EPA (20; 5n-3), DHA, total n-3 fatty acids and the n-3/n-6 ratio for PL and PC 
were lower in the AD, OD and CIND groups than the control. Similarly, for plasma PE, the levels 
of EPA (20:5n-3), DHA, and the total n-3 fatty acid except n-3/n-6 ratio, were significantly lower 
in the AD, OD and the CIND groups. For the LysoPC fraction, there was no statistically significant 
difference in the fatty acid composition (p>0.05) except for DHA that was significantly lower only 
in the CIND group (0.1%) compared to AD (0.49%), OD (0.4%) and normal (0.48%). Plasma 
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phospholipid 24:0 was lower in the AD, OD, and the CIND compared to normal group. Total n-6 
fatty acid levels were lower in the AD and CIND groups only. The study considered age and 
education as important covariates in the statistical analysis using ANCOVA but further 
adjustments for confounding factors would have provided better insight on the relationships of the 
different fatty acids composition in the various plasma lipids and dementia. No information on 
dietary intake or histories were recorded on patients, meaning it is uncertain if patients currently 
consume or previously consumed diets lower in n-3 fatty acids. Also, socioeconomic background 
may have played a role in dietary choices because patient groups were less educated than the 
control group, and education is a gross indicator of socioeconomic level.  
 
 
Cohort studies 
In 2002, Barberger-Gateau et al [5] published a short report in BMJ, suggesting that there was a 
significant association of incident dementia with fish or seafood eating, but not with meat 
consumption. They followed up 1674 participants who aged 68 years and over from the 3rd wave 
survey of the PAQUID epidemiological study of cognitive and functional ageing without dementia 
and living at home in southwestern France. Each participant’s food frequency of consumption of 
meat and fish or seafood was recorded at baseline (1991-2) in four levels. The participants were 
re-examined in 2, 5 and 7 years afterward, and their dementia and AD status was diagnosed using 
MSE or DSM-III-R criteria with the neurologist’s confirmation. In total 1416 participants were 
followed up at least one of the 3 follow-up visits (84.6%). There was a significant increase in the 
risk of dementia with lower level of fish or seafood consumption: the incidence of dementia was 
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1.00 per 100 person years in participants who ate fish/seafood “Once a day”, 2.05 in those who ate 
“at least once a week but not every day”, 2.90 in those “eating from time to time”, and 6.61 in 
those “never eating”. Such a trend was also found for incident AD. In an age-sex adjusted Cox 
regression model analysis, the authors found that participants who ate fish or seafood “at least once 
per week” had a reduced risk of incident dementia (HR 0.66, 95% CI 0.47-0.93) in comparison 
with those consumed at the lower level, but not significantly reduced in the risk of AD (0.69, 0.47-
1.01).  After further adjustment for education (i.e. age, sex and educational level), the reduced risk 
of incident dementia was not significant (0.73, 0.52-1.03). The authors analysed the data of meat 
consumption and found no significant association with the risk of incident dementia (age and sex 
adjusted HR 0.56, 0.26-1.20). The data of AD in relation to meat was not presented in the paper. 
Although the cohort was well followed up, the baseline measurement of fish consumption was 
mixed with other seafood consumptions, and the association between high consumption of fish 
and reduced risk of dementia was not ensured from more confounding adjustment, which was 
missed in the current short report, for example, smoking. In 2 years later, Barberger-Gateau et al[5] 
published a full paper of “Nutritional factors and risk of incident dementia in the PAQUID 
longitudinal cohort” in other journal (Larrieu et al [12]), including additional data on regular fish 
consumers that was omitted previously in the same data of “fish, meat, and risk of dementia: cohort 
study”. They reported that the age-sex-education adjusted RR for AD in participants who ate fish 
or seafood regularly was 0.77 (0.52-1.14) in comparison with those consumed at the lower level, 
but the figure for incident dementia of 0.66 (0.46-0.92) [12] was different from that in the earlier 
paper 0.66 (0.47-0.93) [5]. 
           Barberger-Gateau et al [6] showed a reduction in the risk of dementia and AD among 
frequent consumers of fish, fruit and vegetables and omega-3 fatty acid, particularly among APOE 
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4 negative individual in the Three-City prospective cohort study of vascular risk factors for 
dementia. A sample of 9294 non-institutionalized participants aged ≥65years living in three cities 
(Bordeaux, Dijon, Montpellier) in France were recruited at baseline (1999-2000) and followed-up 
for four years (mean period of 3.48 years) (1999-2004). At baseline, the participants’ dietary intake 
of meat and poultry, fish with seafood, eggs, milk, diary product, dietary fat, cereals with bread 
and starch, raw fruit and vegetable, pulses and cooked fruit or vegetable were examined using a 
short food frequency questionaries’ subdivided into 6 consumption level. The participants’ 
sociodemographic data were also documented at the preliminary stage of the study. Participants 
underwent three-step procedures to establish their dementia status. This involved the 
administration of battery of neuropsychological tests by an expert in psychology, after which a 
neurologist re-examined the participants to ascertain the diagnosis. An independent team of 
neurologists finally reviewed the diagnosis using the DSM-IV criteria for dementia and the 
NINCDS- ADRDA for AD. Over a follow-up period of 4 years, a sample of 8085 (89.1%) non-
demented participants were examined at least once. A total of 281 dementia cases (144 at 2 years 
and 137 at 4years follow up) emerged with 183 cases of AD within these period. The result showed 
a non-significant reduction in the risk of dementia among two of the fish intake level of 
consumption (highest and lowest intake level) after adjusting for confounding variables. No 
relationship was found between the intake of corn oil, peanut oil, lard, meat, or wine and the risk 
of all cause dementia in an age adjusted univariate analysis (p >0.25) hazard Ratio (HR) (not 
reported). Using a multivariate adjusted analysis model, a significant reduced risk of dementia was 
found among participants that consume fish 2-3 times a week with HR of 0.68(0.48-0.98), 
0.81(0.57-1.17) among once/week fish consumers and 0.81(0.45-1.46) among ≥4 times/week fish 
consumers, when sex, education, city, income, and marital status, were added into the adjusted 
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model and compared with the never/<once/week fish consumers. Similar trend was also 
encountered for the risk of AD. Since fish intake, ApoE genotype and dementia risk had an 
interaction, when two of the three interaction terms were considered, the already adjusted model 
was stratified by ApoE, and the result showed a beneficial effect between the intake of fish and 
the risk of all cause dementia among only the ApoE non-carriers participants with HR of 0.53(0.34-
0.82) at 2-3 times/week fish consumption level, 0.66(0.42-1.01) at fish intake level of once a week 
and 0.80(0.41-1.58) at fish intake level of ≥4 times/week. After further adjustment for BMI and 
diabetes, there was a slight change in the result. A non-significant reduced risk of AD was found 
in two of the fish intake level of (≥4 times/week and once a week) when ApoE genotype was 
introduced into the already adjusted model. There was a slight changed in HR for AD risk when 
the model was further adjusted with BMI and diabetes.  A borderline significant reduction in the 
risk of dementia was realized among regular fish eaters of (at least once a week) with HR 
0.75(0.54-1.04). When ApoE4 status was added into the adjusted model, a significant reduction in 
the risk of dementia was obvious only among the non-carriers of APOE4 with HR 0.60(0.41-0.89), 
and with no significant association among the APOE4 carriers with HR 1.28(0.58-2.83). The 
beneficial effect was maintained among the ApoE 4 negative, when further adjustment was made 
with BMI and diabetes with HR of 0.60(0.40-0.90). The same significant trend was maintained in 
the risk of AD among regular fish eaters after adjusting for APOE genotype, BMI, and diabetes 
with HR of 0.65(0.43-0.994). A 60% reduced risk of dementia was found among frequent omega 
3 rich oils consumers after adjusting for confounders, but no significant reduction was found for 
intake of any other kind of dietary fat. The findings remained practically unaffected when APOE 
genotype, BMI and diabetes was introduced into the adjusted model. Consumption of fruit and 
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vegetables lead to reduced risk of all cause dementia, giving a HR of 0.72 (0.53-0.97) in a fully 
adjusted model. 
This cohort study had enough years of follow up, but their preliminary fish consumption data 
collection was along with seafood and other types of foods. The study acknowledged that despite 
controlling for possible confounders, there might still be the presence of some residual 
confounders, which could have impacted on the findings. 
            Devore et al [7] investigated the association between dietary intake of fish and omega-3 
polyunsaturated fatty acids (PUFA) in relation to long-term dementia risk. In the year 1990, 7983 
(78%) eligible inhabitants of Ommoord aged 55 years or more were recruited at baseline based on 
agreement in the Rotterdam population based Study. At the commencement of the study, health 
and lifestyle information were collected between 1990-1993. This involve an extensive home 
interview and 2 clinical assessments of both male and female participants. 7046(88%) of the 
chosen cohort were checked incessantly throughout the mean follow up period of 9.6 years for 
death rate and disease state of participants. Cognitive screening was performed on all participants 
at baseline and they were all confirmed free of dementia. 6444 participants were left after exclusion 
of 602 due to questionable cognitive status and bias in diet recall mainly because of living in 
nursing home. After further exclusion of 1049 participants were due to inconsistencies in dietary 
response, missing the last visit and not having a dietician available at the last visit. This reduced 
the final cohort to 5,395 participants that were dementia free and had complete dietary information 
for analysis. A 2-step protocol was employed to collect dietary intake data. This include: a meal-
based check list to prompt recall of food that were previously consumed at least twice/month A 
validated 170 items semi-quantitative (SFFQ) was later employed to collect the frequency of fish 
intake from each participant by a trained dietitian. This frequency was recorded in times per day, 
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week, or month.  Total fish intake was assessed using 3 categories: (none, low and high); while 
the fish type was (none, lean and fatty fish). Total Omega-3 PUFA (EPA+DHA), and ALA, EPA, 
DHA was also calculated for each participant. A 3-step protocol was used at baseline for dementia 
diagnosis: These comprises of MMSE and Geriatric mental state (GMS) schedule. Those that 
present with MMSE scores of <26 or GMS scores >0 underwent the Camdex test, and suspected 
participants with dementia were further evaluated by a neurologist and neuropsychologist using 
neuroimaging data to identify brain abnormalities. Further monitoring of participants was done to 
establish any memory problem and dementia state using a computerized linkage of dataset and 
digitalized medical records. Lastly, the dementia diagnosis was confirmed using 3 experts’ 
committee following the DSM-III-R criteria for dementia, NINCDS-ADRDA for AD, and 
NINDS-AIREN for vascular dementia.  465 new cases of dementia were developed over 9.6 years’ 
follow-up period (with 365 AD cases). 
Using an age-sex adjusted Cox hazard model, total fish consumption was not associated with long-
term risk of dementia and AD.  Participants with higher fish consumption level (29.6g/day) showed 
HR of 0.93 (95%CI 0.74-1.17) and 0.99(0.77-1.29) in relation to the risk of dementia and AD 
respectively, when compared to never fish eaters over a longer period. Further adjustment with 
education, total energy intake, alcohol intake, smoking, BMI, high total cholesterol, baseline 
hypertension, intake of vitamin E, supplement use, history of stroke, myocardial infarction (MI) 
and type 2 diabetes, showed HR of 0.95(0.76-1.19) for dementia and 0.99(0.76-1.29 for AD when 
compared to never fish eaters. Participants with low fish consumption level (8.2g/day) in relation 
to dementia risk, showed HR of 0.91(0.73-1.14) and 1.05(0.82-1.34) for AD when adjusted for 
age and sex. After further adjustment with potential confounders, the HR for dementia risk was 
0.94(0.75-1.17) and 1.07(0.83-1.37) for AD, when compared to never eaters.  When fish type (fatty 
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fish) was considered and compared with never consumers of fish, similar HR 0.98(0.77-1.24) for 
risk of dementia was found, which was quite the same as the AD result (HR not reported).   No 
relationship was found with increased intake of omega-3 PUFA and the risk of dementia and AD, 
despite using only age or multivariate adjusted model. The age-adjusted model for dementia risk 
showed HR of 0.93(0.74-1.16) when the highest (3rd) tertile intake of omega-3 PUFA was 
compared with the lowest (1st) tertile omega-3 intake level, and HR of 0.90(0.73-1.12) when the 
2nd tertile omega-3 PUFA intake level was compared with the lowest tertile. No association was 
also found with dementia risk when higher tertile of long chain omega-3 PUFA was compared 
with lower tertile of omega-3 PUFA with HR 0.97 (0.77-1.21) in the multivariate adjusted model. 
This was quite similar  to that of AD with HR of 1.05(0.81-1.36).  
This same trend of no relationship of dementia risk was also found when the highest tertile intake 
of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and alpha-linoleic acid (ALA) were 
considered independently with HR of 0.97(0.77-1.21) and 0.99(0.79-1.24) (HR of ALA not 
reported), in comparison with lowest tertile in the multivariate adjusted models. The HR of 2nd 
tertile EPA and DHA intake level for risk of dementia, when compared with their lowest tertile 
intake level was 0.87(0.70-1.08) and 0.91(0.73-1.13) respectively (HR for ALA not reported). 
Further analysis was done by comparing shorter follow up years (0-8) with longer years (9-14). 
The follow up period of 0-8 years showed a non-significant reduced risk of Alzheimer’s disease 
with higher fish and long chain omega-3 PUFA intake with HR 0.78(0.53-1.16) and 0.76(0.51-
1.13) respectively, but no relationship was found over a period 9-14 years with HR 1.20 (0.85-
1.72) for higher fish consumption and 1.16(0.84-1.60) for highest omega-3 PUFA intake. Same 
trend was reported when EPA and DHA was considered separately. Similar trend was also reported 
for risk of dementia, but the HR result was not shown. 
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The large prospective design of this study with its longer follow-up as well as a significant number 
of dementia cases contributed immensely to the long-term risk estimates. This study considered 
varieties of confounding variables but this did not substantially affect the result. The baseline 
dietary information data collected might not have shown a positive reflection of the food intake 
level of the participants over a longer period. Higher consumption of cod fish (lean) limited the 
ability of this study to specifically evaluate the association that fatty fish have with the risk of 
dementia. 
         Morris et al [8] acknowledged a reduction in the risk of Alzheimer’s disease (AD) after 
dietary consumption of fish and omega 3 polyunsaturated fatty acids (PUFA) in the Chicago 
Health and Aging population based study of risk factors for AD. 8501 inhabitants aged ≥65 years 
were selected between 1993 and 1997 in the south-side Chicago, III, community census. Among 
this selected population, a total of 6158 (78.8% out of 7813 survivors) partook in an hour and a 
half interview that involves the 4 cognitive tests assessment. 65% of the population was classified 
as black, 38% as white, with a mean educational level of 11.8 years. Of the interviewed population, 
1056 participants were chosen randomly from a sample stratified by age, sex, race, cognitive 
behaviour (good, intermediate, or poor) for clinical examination detect AD prevalence. From this 
population, 729 (76% of 961 survivors) were assessed. The preliminary stage of this study 
acknowledged 3838 cohorts with absence of AD (3352 with good cognitive performance and 486 
with poor cognitive performance but no AD). A follow-up interview was conducted on 4320 
participants (86.7% of 4983 survivors) that responded after the 3 years’ baseline data collection. 
A total of 1249 participants were randomly chosen from this sample for clinical assessment to 
detect new AD cases through stratification by age, sex, race, decrease in cognitive behaviour (no, 
minor, major decrease). From this random selection, 842 (73.9% of 1140) individuals accepted to 
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participate, but only 815 participants provided complete data for analysis. During a mean period 
of 1.9 years after the participants’ preliminary assessment or 2.3 years before their clinical 
examination, their dietary intake was examined using a modified 154-questions with 139 items 
Harvard self-administered food frequency questionnaire (FFQ). This comprises of 4 seafood 
(shrimps/lobster, crabs, fresh fish, tuna fish sandwich, fish sticks/fish cakes/ fish sandwich) and 
other food items, among which are (meat product, vitamin supplement). The participants AD status 
was established using well organised neurologic clinical assessments that comprises of specialists’ 
team of neurologist, phlebotomist, nurse, and neuropsychological technician. Following the 
expert’s judgement, the participants’ full medical history, laboratory examination, assessment of 
participant cognitive status through interview, medication use, neurological assessment, and 
neuropsychological status was investigated. Magnetic resonance imaging (MRI) was incorporated 
into the examination for only those participants that display signs of being demented or has 
undefined level of their stroke status. Using standardized diagnosis criteria of the National Institute 
of Neurological and Communicative Disorders, Stroke and Alzheimer’s disease and Associated 
Disorders Association (NINCDS-ADADA) their AD status was established by a neurological 
expert blinded from the cohort food intake.  
In an age adjusted logistic regression model, a non-significant reduced risk of AD with Relative 
risk (RR, 0.5 95% CI 0.2-1.0) was found among fish consumers of at least once/week, (0.6, 0.2-
1.4) for ≥twice/week and (0.7, 0.3-1.6) for 1-3 times/month in comparison with never fish 
consumers. After further adjustment with sex, race, education, presence of APOE4, and total 
energy intake, a similar 60% significant reduced risk of AD was shown across two of the fish 
consumption level of once/week and ≥ twice/week with RR (0.4, 0.2-0.9), while a non-significant 
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reduced risk of AD was still maintained at fish consumption level of 1-3times/month with RR (0.6, 
0.3-1.3) despite the adjustment for confounders. 
Furthermore, in a multivariate adjusted model (age included), a significant reduction in the risk of 
AD was found after intake of total omega-3 PUFA. This controlled for race, sex, age, total energy 
intake, APOE4 status, education, (race x APOE4 interaction), period of observation, indicator 
variables for fish consumption 1-3 times per month, once per week and 2 or more times a week. A 
70% significant reduced risk of AD was found after adjusting for age, when the participants at the 
highest intake level of omega-3 PUFA (5th quintile) was compare to those at the lowest intake level 
( 1st quintile) with RR (0.3, 0.1-0.7). The significant association was maintained with a minor 
change in the relative risk (0.4,0.1-0.9) after further adjustment with probable confounders. Two 
of the total omega-3 PUFA intake levels (3rd and 4th quintile) showed a non-significant association 
with the risk of AD when fully adjusted with RR 0.6 (0.2-1.7) and 0.7 (0.3-1.6) respectively, while 
the 2nd quintile intake level showed an increased risk of AD with RR 1.2 (0.5-3.0) in comparison 
with the lowest quintile. More beneficial effect was found with the risk of AD when only the intake 
of docosahexaenoic acids (DHA) 22:6 n-3 was considered instead of the total omega-3 fatty acid 
intake with RR 0.3 (0.1-0.9) when the 5th highest quintile was compared with the 1st lowest 
quintile, after adjusting for all the possible confounding variables.  
This study was able to establish the beneficial association that DHA have with AD risk, which 
eliminate the uncertainty of the result. The use of the random sampling technique for the 
participants’ selection minimized the issue of bias in this study. Also, the investigators were unable 
to collect the dietary intake data at baseline from many of the participants. This could have affected 
the result, if the disease as already manifested when their diet was later evaluated during the 
research. 
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        Schaefer et al [9] established a reduced risk of developing dementia and AD with plasma 
phosphatidylcholine (PC) docosahexaenoic acid (DHA) content in the Framingham Heart Study. 
During the year 1986/88, 1921 males and females’ participants aged between 55 and 88 years who 
were living and free of dementia were recruited at the 20th biennial examination 14-15 cycles in 
the United State. 899 (74.4%) participants from the 1208 (62.9%) sample with at least one year of 
follow up that took part in the baseline examination, provided plasma sample for PC fatty acid 
assessment and this constituted the study population, out of which 488 participants (54.3%) 
provided dietary information. They all had a followed-up period of 16 years with an (average of 
9.1years). Dietary fish and DHA intake were examined using a 126-item semi-quantitative food 
frequency questionnaire (FFQ). The participants were expected to have received and filled the 
questionaries’ before the 20th biennial examination. Total energy intake < 600 calories and >4200 
calories excluded. Fish intake was estimated in servings/week. At baseline, this was 2.0 (2.0) for 
men and 2.1 (1.8) for women. The baseline plasma PC DHA levels was assessed using four 
quartiles. Mini-Mental State Examination (MMSE) was performed on each participant at every 
biennial examination. Those that scored less than the education-based cut-offs or had lost ≥ 3 
points on the MMSE, further had a neurological and a neuropsychological investigation.  A 
comprehensive case review by board of at least 2 neurologists and neuropsychologist were 
conducted for each dementia diagnosis. The dementia and Alzheimer’s (AD) diagnosis were 
determined using the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) and National Institute of Neurological and Communicative Disorders and Stroke-
Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria respectively. 
All established dementia cases after the 20th biennial examination were included, while the 
previously established cases were excluded from the analysis. 99 new cases of dementia occurred 
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during a mean follow up of 9.1 years with (71 AD cases). In an age-sex adjusted Cox proportional 
hazards regression model, a significant reduced risk of incident all-cause dementia was found 
among the participants in the plasma PC DHA highest quartile in comparison to those in the lowest 
quartile with RR of 0.53(95%CI 0.29-0.98). Further adjustment with APOE allele, homocysteine 
concentration, and educational level, the RR was changed to 0.52(0.26-1.04), making this non-
significant. However, when subjects with plasma PC DHA levels in the upper quartile were 
compared with all 3 lower quartiles combined, the RR was 0.53 (95% CI 0.29-0.97) after 
adjustment.  
A non-significant reduced risk of AD was found when the participants in the highest plasma PC 
DHA quartile level was compared with the other 3 lower quartiles with a RR 0.60(0.32-1.12), 
when age and sex was adjusted, 0.59 (0.31-1.14) when APOE allele was added into the adjusted 
model, and finally 0.61(0.31-1.18) when plasma homocysteine concentration and educational level 
was further introduced into the already adjusted model. No substantial change in the results for 
both the risk of dementia and AD was observed when BMI, hypertension, diabetes mellitus, 
smoking, alcohol intake, stroke history was later added to the already adjusted model with RR of 
0.54(0.29-0.98) compared to to 0.53 (0.29-0.97) for all-cause for dementia and 0.62(0.32-1.22) 
compared to 0.61 (0.31-1.18) for AD. No significant relationship was found with all-cause 
dementia and AD risk, with plasma PC level of linoleic acid, α-linolenic acid, eicosapentaenoic 
acid, palmitic acid, oleic acid, arachidonic acid, stearic acid in an age-sex adjusted model except 
with the RR 1.27(1.01-1.61) for plasma PC level of linoleic acid in association with AD risk. The 
significant association changed when APOE, educational level and homocysteine was introduced 
into the adjusted model with RR 1.24(0.97-1.59). 
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A non-significant reduced risk of dementia and AD was found among participants at upper quartile 
dietary DHA intake level when compared to those at lower 3quartiles dietary intake level after 
adjusting for probable confounders with RR of 0.56(0.23-1.40) for dementia and 0.63(0.23-1.72) 
for AD. In the participants that consumed fish for ≥twice/week when compared with those that 
consumed fish for at most twice/week, a non-significant reduction in the risk of dementia and AD 
was found with RR of 0.61(0.28-1.33) and 0.50(0.20-1.27) respectively. This cohort study had a 
long follow up period and the first study to investigate the relationship of plasma PC DHA content 
with incident dementia and AD.  The plasma PC DHA level was measured only once during the 
data collection period, and dietary data was only available for a subset of the sample which were 
non-randomly selected.  
        In 2011, Lopez and colleagues [10] published an article in the Journal of Nutrition, Health 
and Aging suggesting that Plasma and dietary DHA may protect against dementia, with fish intake 
exhibiting similar but non-significant effect.  They recruited 402 community dwelling individuals 
who participated in two separate research visits at a clinic in both 1988-91 and 1991-93.  All of 
them had their dietary DHA and fish consumption data recorded at the first visit in 1988-91. At 
the next visit in 1991-93, a total of 266 eligible male and female participants aged ≥65 years were 
selected and had their plasma DHA recorded. Only 242 had both dietary and fish consumption 
data.  Cognitive function test and clinical examination were done by a psychometrics and 
neurologist followed by a computerised tomography brain scan two weeks later. Three exposure 
variables were considered and they included plasma DHA, dietary DHA and consumption of dark 
meat fish. To adjust for skewed distribution, plasma and dietary DHA were log transformed and 
modelled as continuous, categorical (tertiles) and lowest tertile vs other tertiles. Fish intake was 
considered as; rarely or never, 1-3 times per Month, 1 time per Week, 2-4 times per Week, 5-6 
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times per Week, daily and 2 times per day.  All-dementia and AD cases (outcome variables) were 
diagnosed based on data of psychometrist cognitive function test, neurologist clinical examination, 
computer aided brain scan and NINICDS-ADRDA criteria. The findings from multivariate logistic 
regression after adjusting for age, sex, education, ApoE4 and history of stroke showed significant 
reduction of the Odds for all cause dementia by 65% for the highest tertile in Plasma DHA (95%CI: 
0.17-0.92) and by 60% for AD (95%CI: 0.15-1.10). The outcome for dietary DHA was similar, 
with the Odds significantly reduced by 73% for all-cause dementia (95%CI: 0.09-0.79) and by 
72% for AD (95%CI: 0.09-0.93). The findings using continuous DHA showed non-significant 
reduction of the Odds for all cause dementia (OR: 0.72, 95%CI: 0.49-1.05) and AD (OR: 0.76, 
0.50-1.14) in the plasma DHA. However, for higher dietary DHA (as per log SD increase), the 
Odds was significantly reduced by 47% for all-cause dementia (95%CI: 0.34-0.81) and by 48% 
for AD (95%CI: 0.32-0.84). On the contrary, the findings for the lower tertile when compared to 
the two highest tertiles showed significantly increased odds for all cause dementia (OR: 2.35, 
95%CI: 1.12-4.92) and AD (OR: 2.33, 95%CI: 1.04-5.21) in the Plasma DHA.  The Odds were 
even higher in the dietary DHA, for all-cause dementia (OR: 4.31, 95%CI: 1.87-9.92) and AD 
(OR: 3.43, 95%CI: 1.42-8.26). Further adjustments for Systolic B.P, smoking, alcohol, exercise, 
diabetes and BMI did not alter the associations in the analysis of the highest tertile or continuous 
data for plasma and dietary DHA. The odds did not substantially change in any of the analysis 
when carriers of the ApoE4 Allele gene were excluded. Fish consumption of at least one serving 
per week, had 49% reduced odds for all-cause dementia (95%CI: 0.20-1.32) and 45% for AD 
(95%CI: 0.20-1.48). However, the results were not significant, likely due to the relatively small 
number of participants eating at least one serving of fish per week (n=43) and due to the 
misclassification of annual food frequency questionnaires.  It was also observed that fewer people 
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(242) participated in the study of dietary intake of fish and dementia compared to those for plasma 
DHA (266) which formed basis for the report. The early part of the report suggested a case cohort 
design was used, but only the sample for plasma DHA analysis was taken once on the spot without 
any repeat, which was similar to a cross sectional design approach. Therefore, causality cannot be 
inferred from the findings. 
       Huangs and colleague [11] demonstrated a reduction in the risk of dementia and Alzheimer’s 
disease (AD) with fatty fish intake, while lean fried fish had no beneficial effect especially with 
APOE4 non-carriers in the Cardiovascular Health Cognition Study (CHCS). At baseline, 5201 
participants aged ≥ 65 years were randomly recruited between the year 1989 and 1990 from the 
Medicare eligibility list of four communities in the US (Forsyth County NC, Washington County 
MD, Sacramento CA, Pittsburgh PA) that were selected for the Cardiovascular Health Cognitive 
Study (CHCS). A total of 687 African American individuals were further recruited from three of 
the four communities (Forsyth, Sacramento, Pittsburgh) two years after the preliminary 
recruitment between 1992 and 1993. 3602 participants that underwent brain MRI between the year 
1992-1994 and have simultaneously completed the modified mini-mental state examination 
(3MSE) were examined in 1998 during the commencement of the CHCS study. Of these, 2,233 
people were followed- up between 0.1-8.4 years with a mean of 5.4 years from the time the MRI 
examination was conducted and the start of AD, dementia or death. This study excluded all the 
participants that presented with prevalence of dementia (227) and mild cognitive impairment 
(MCI) (577). Additional 565 participants were eliminated due to insufficient data for fish 
intake/energy intake evaluation/ responses from extra 12 food items from the FFQ or extreme 
energy intake values. Additional variables that were collected at baseline, apart from dietary 
intakes, included education, age, gender, race, BMI and income. APOE genotype was assessed 
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through DNA analysis from 91.5% of the participants. Various eating styles and habits, including 
fish consumption of each participant was assessed using a modified National Cancer Institute 
(NCI) 99-item FFQ with 46 extra questions on style and habit of food consumption. Fish 
consumption was assessed in four categories of number of servings per week which included; 
<0.25, 0.25-2, 2-4 and ≥4 for fatty fish (other fish and tuna). For lean fried fish, it included; <0.25, 
0.25-2 and ≥2 servings per week. Participants dementia status were diagnosed using the MMSE, 
and 3MSE at baseline (1989-1990) and afterward. Participants that were absence from the clinic 
were investigated via a Telephone Interview for Cognitive status (TICS), while the Informant 
Questionnaire for Cognitive Decline in the Elderly (IQCoDE) was used to collect information from 
close relatives, GP, and caregivers of the deceased participants. All participants classified as high 
risk based on 80-point cut off on the 3MSE, a decline of at least 5 points on the 3MSE from 
previous examinations, a TICS score of <28, an IQCoDE score of >3.6, a stroke, a medical record 
review with a diagnosis of dementia, or residence in a nursing home), all participants at the 
Pittsburgh site and all minorities completed a neuropsychological test battery and were further 
assessed by neurologist if tests of memory or greater than one cognitive domain were failed (If 
refused / unable to attend clinic, or was deceased, dementia was assessed using the prospectively 
collected data from the annual clinic examination, enhanced with data from medical records, 
physician questionnaires, and informant/proxy interviews (including the Dementia Questionnaire). 
Finally, team of psychiatrists and neurologist certify the dementia status of participants’ if there is 
presence of a progressive or static cognitive deficit severe enough to affect ADLs, an earlier normal 
level of intellectual functioning, impairment in ≥ 2 cognitive domains that does not necessarily 
consist of memory, and if the DSM-IV criteria were fulfilled. National Institute of Neurological 
and Communicative Disease and Stroke-Alzheimer’s Disease and Related Disorders Association 
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(NINCDS-ADRDA) criteria was used to ascertain AD status, and NINCDS-ADDTC was used for 
vascular dementia (VaD). Of the 2233 assessed participants, 378 had dementia, 190 AD, 50 had 
pure VaD. No significant difference was found in the incident of dementia or AD with greater 
servings of fried fish per week either before or after adjusting for fatty fish, age at baseline, 
minority status, gender, presence of APOE e4, energy, BMI, region, education, or income. 
Using a univariate analysis model, the result shows a non-significant decrease in the incident of 
dementia (HR 0.75 (95% CI 0.55-1.03) and AD (HR: 0.69 (0.45-1.06) when tuna or other non-
fried fish was consumed once/month to twice/week in comparison to very low or non-
consumption. Also, the consumption of tuna or other non-fried fish ≥ 4times /week, was 
significantly associated with protection against dementia (HR: 0.63(0.44-0.90)) and AD (HR: 
0.56(0.34-0.91)).  
Using a Cox hazard regression model, these associations were not significantly affected after 
adjusting for age at baseline, sex, minority status, presence of APOEe4, energy, BMI, region, and 
fried fish intake (model 1), for consumption of tuna or other non-fried fish the HR for dementia 
was 0.65 (0.43-0.98) for ≥4times/week intake, 0.72(0.51-1.02) for intake of 2-4 servings/week and 
0.76(0.55-1.06) for 0.25-2 servings/week when compared to <0.25 servings/week. For AD the HR 
was 0.54(0.31-0.95) for consumption of tuna or other non-fried fish ≥4times /week, 0.59(0.36-
0.95) for 2-4 servings /week and 0.72(0.46-1.12) for 0.25-2 servings /week when compared to 
<0.25 servings / week. After further adjustment with education and income (model 2) HR’s were 
attenuated for consumption of tuna or other non-fried fish. HR for dementia was 0.79(0.53-1.20) 
for ≥4times/week, 0.83(0.59-1.18) for 2-4 servings /week and 0.85(0.61-1.19) for 0.25-2 servings 
/week.  For AD, HR was 0.69(0.91-1.22) for ≥4times /week, 0.72(0.44-1.17) for 2-4 servings 
/week and 0.85(0.54-1.33) for 0.25-2 servings /week when compared to <0.25 servings / week. A 
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non-significant reduced risk of dementia and AD with total fish consumption was attained with 
fully adjusted HR of 0.87(0.62-1.23) for >1 servings/month to 2 servings/week of total fish for 
dementia and 0.78(0.48-1.28) for AD.  
A non-significant increased risk of dementia with HR 1.11(0.76-1.47) was found for intake of ≥2 
servings/week of fried fish in (model 1) and 0.97(0.69-1.35) in model 2 when compared with < 
0.25 servings/week, while HR 1.18(0.92-1.52) was found for consumption of 0.25-2 
servings/week of fried fish in model 1 and HR 1.12(0.87-1.44) in model 2. For AD, a non-
significant increased risk of HR 1.06(0.66-1.69) was found for ≥2 servings/week of fried fish in 
(model 1) and 0.95(0.60-1.52) in model 2, while HR 1.07(0.74-1.54) was found for 0.25-2 
servings/week of fried fish in model 1 and HR 0.97(0.67-1.40) in model 2, when compared with 
<0.25 servings. HR of 2.6(1.39-4.96) with increased risk of vascular dementia (VaD) was revealed 
after intake of 0.25-2 servings of fried fish/week but the HR of 1.68(0.74-3.84) at fried fish intake 
level of 2-4 servings/week was not significantly associated with VaD. Similar findings were found 
after adjusting for confounding variables. The HR result for VaD risk in relation to fatty fish intake 
was like that of the risk of dementia but the findings were not reported. Findings from the analysis 
of dementia outcome and tuna or other fish stratified by APOE e4 status showed a small or no 
relationship among APOEe4 positive participants that consumed 2-4 servings/week of fatty fish 
with HR 0.91(0.48-1.71), while the APOEe4 negative participants showed significantly lower HR 
0.60(0.40-0.89) after consuming 2-4 servings/week of fatty fish. The HR was maintained for 
APOEe4 negative participants after controlling for confounders in model 1 but the association was 
attenuated in model 2. Adjusting for age, minority status, sex, APOE e4, energy, BMI, region, and 
fried fish in model 1 showed HR of 0.91 (0.44-1.88) among APOE e4 positive participants with 
≥4 servings per week compared to < 0.25, and further adjustment using education and income 
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(model 2) showed HR 1.03 (0.49-2.16). The HRs for 2-4 servings/week were 0.99 (0.52-1.89) and 
1.06 (0.55-2.05) for model 1 and model 2; and for 0.25-2 servings/week the HR was 1.07 (0.58-
1.98) and 1.23 (0.66-2.30) for model 1 and 2 respectively. For APOEe4 negative participants that 
consumed ≥4 serving/ week of tuna or other fish, the HR for model 1 was 0.54(0.31-0.95), HR 
for 2-4 servings of fish was 0.59(0.36-0.95) and for 0.25-2 servings of fish the HR was 0.72(0.46-
1.12), compared to <0.25 servings/week. Further adjustment (model 2) showed HR 0.69(0.91-
1.22) for ≥4 servings per week, HR 0.72(0.44-1.17) for 2-4 servings/week, and 0.85(0.54-1.33) for 
0.25-2 servings/week of tuna or other fish, compared to <0.25 servings/week. A reasonable mean 
follow-up year was achieved in this cohort study with adjustment made with several probable 
confounders. This study reported that they are the first to establish the relationship of fish 
consumption with APOE4 alleles carrier and non-carrier. They mentioned that their baseline 
dietary assessment instrument was not with portion sizes, and the fish consumption frequency was 
restricted to 5 subdivisions. 
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